1
|
Xu LP, Yao L, Li LP, Zhou ZK, Xu YY. [Endoscopic diagnosis of intestinal Talaromycosis marneffei: report of two cases]. Zhonghua Bing Li Xue Za Zhi 2024; 53:398-401. [PMID: 38556827 DOI: 10.3760/cma.j.cn112151-20230920-00197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/02/2024]
Affiliation(s)
- L P Xu
- Department of Pathology, the First Hospital of Nanchang, Nanchang 330006, China
| | - L Yao
- Department of Digestive Internal, the First Hospital of Nanchang, Nanchang 330006, China
| | - L P Li
- Department of Clinical Laboratory, the First Hospital of Nanchang, Nanchang 330006, China
| | - Z K Zhou
- Department of Pathology, the First Hospital of Nanchang, Nanchang 330006, China
| | - Y Y Xu
- Department of Pathology, the First Hospital of Nanchang, Nanchang 330006, China
| |
Collapse
|
2
|
Xu YY, Chen QH, Liu Y, Ji C, Du J, Li MY, Shen HP, Zhang XC, Che XR, Zhao G. [Research progress of vaccination status, efficacy and safety in children with tumor]. Zhonghua Yu Fang Yi Xue Za Zhi 2024; 58:87-91. [PMID: 38228554 DOI: 10.3760/cma.j.cn112150-20230213-00101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 01/18/2024]
Abstract
Malignant tumors in children are one of the most important diseases that threaten the health and quality of life of children and are the second most common cause of death in children.With the continuous improvement and progress of treatment technology, the long-term survival rate of children with tumor has been significantly improved, but both the disease itself and the treatment can impair the immune function of children, which makes them vulnerable to various infectious diseases and secondary serious complications, and even become a source of infection, endangering the health of others. Vaccination is the most cost-effective measure to prevent infectious diseases. For children with normal immune functions, the benefits of vaccination usually outweigh the disadvantages. However, there is a lack of detailed data on the vaccination situation, efficacy and safety of vaccine use for such immunocompromised tumor survivors, and there are no authoritative and uniform vaccination recommendations. This article reviewed and summarized the literature and consensus of some domestic and foreign scholars on current status of post-treatment vaccination status, efficacy and safety of vaccination for children with tumors after treatment, with the aim of providing a reference for the practice in this field in China.
Collapse
Affiliation(s)
- Y Y Xu
- Department of Expanded Program on Immunization, Hangzhou Center for Disease Control and Prevention, Hangzhou 310021, China
| | - Q H Chen
- Department of Expanded Program on Immunization, Linping Center for Disease Control and Prevention, Hangzhou 311100, China
| | - Y Liu
- Department of Expanded Program on Immunization, Hangzhou Center for Disease Control and Prevention, Hangzhou 310021, China
| | - C Ji
- Department of Pediatric Health Care, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310000, China
| | - J Du
- Department of Expanded Program on Immunization, Hangzhou Center for Disease Control and Prevention, Hangzhou 310021, China
| | - M Y Li
- Department of Pediatric Health Care, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310000, China
| | - H P Shen
- Department of Pediatric Health Care, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310000, China
| | - X C Zhang
- Department of Expanded Program on Immunization, Hangzhou Center for Disease Control and Prevention, Hangzhou 310021, China
| | - X R Che
- Department of Expanded Program on Immunization, Hangzhou Center for Disease Control and Prevention, Hangzhou 310021, China
| | - G Zhao
- Department of Expanded Program on Immunization, Hangzhou Center for Disease Control and Prevention, Hangzhou 310021, China
| |
Collapse
|
3
|
Lu ZJ, Liu Y, Du J, Wang J, Che XR, Jiang W, Zhang XP, Gu WW, Xu YY, Zhang XC, Wang J, Xie QX, Yang YY, Gu LT. [Effectiveness of 13-valent pneumococcal conjugate vaccine against invasive disease caused by serotype 19A in children: a meta-analysis]. Zhonghua Yu Fang Yi Xue Za Zhi 2023; 57:2181-2187. [PMID: 38186174 DOI: 10.3760/cma.j.cn112150-20230223-00149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 01/09/2024]
Abstract
Objective: Using Meta-analysis to evaluate the vaccine effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) against invasive Streptococcus pneumoniae disease (IPD) caused by serotype 19A in children <5 years old. Methods: "Streptococcus pneumoniae infection""invasive pneumococcal disease""13-valent pneumococcal polysaccharide conjugate vaccine""PCV13""effectiveness""infant""child" and related terms were searched from China National Knowledge Infrastructure (CNKI), WANFANG DATA, PubMed, SCOPUS and Web of science with no limited on language, region and research institution. The retrieval time was limited from January 2010 to February 2023 and cohort study, case-control study and randomized controlled trial were included. Data were extracted from eligible studies by two independent reviewers, and after study quality assessment by NOS scale, Meta-analysis was completed using Stata 16.0 software. Results: A total of 2 340 related literatures were searched, and 10 literatures were finally included, including 5 case-control studies and 5 indirect cohort studies, which showed good literature quality. The vaccine effectiveness against serotype 19A IPD of PCV13 in children was 83.91% (95%CI: 78.92%-88.89%), and the subgroup analysis (P=0.240) showed there was no significant difference among the case-control study (VE=87.34%, 95%CI:79.74%-94.94%) and the indirect cohort study (VE=81.30%, 95%CI:74.69%-87.92%). The funnel plot and Egger test suggested that the possibility of publication bias was small. Conclusion: The present evidence indicates that PCV13 has a good vaccine effectiveness against serotype 19A IPD in children, and it is recommended to further increase the vaccination rate of PCV13 to reduce the disease burden of IPD in children <5 years old.
Collapse
Affiliation(s)
- Z J Lu
- Department of Immunization Program, Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - Y Liu
- Department of Immunization Program, Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - J Du
- Department of Immunization Program, Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - J Wang
- Department of Immunization Program, Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - X R Che
- Department of Immunization Program, Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - W Jiang
- Department of Immunization Program, Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - X P Zhang
- Department of Immunization Program, Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - W W Gu
- Department of Immunization Program, Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - Y Y Xu
- Department of Immunization Program, Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - X C Zhang
- Department of Immunization Program, Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - J Wang
- Department of Immunization Program, Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - Q X Xie
- Department of Immunization Program, Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - Y Y Yang
- Department of Immunization Program, Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - L T Gu
- Department of Immunization Program, Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| |
Collapse
|
4
|
Li LS, Guan K, Yin J, Wang LL, Zhi YX, Sun JL, Li H, Wen LP, Tang R, Gu JQ, Wang ZX, Cui L, Xu YY, Bian SN. [Risk factors of systemic allergic reactions caused by subcutaneous allergen immunotherapy]. Zhonghua Yu Fang Yi Xue Za Zhi 2023; 57:1972-1977. [PMID: 38186144 DOI: 10.3760/cma.j.cn112150-20230703-00500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 01/09/2024]
Abstract
Objective: To investigate the incidence and risk factors of systemic allergic reactions induced by subcutaneous immunotherapy (SCIT) in patients undergoing SCIT injections in Peking Union Medical College Hospital (PUMCH). Methods: This is a single center retrospective cohort study. Using the outpatient information system of PUMCH, the demographic information and injection-related reaction data of patients undergoing SCIT injection in Allergy Department of PUMCH from December 2018 to December 2022 were retrospectively analyzed to count the incidence and risk factors of systemic allergic reactions caused by SCIT. Mann-Whitney nonparametric test or chi-square test was used for single-factor analysis, and multiple logistic regression was used for multiple-factor analysis. Results: A total of 2 897 patients received 18 070 SCIT injections in Allergy Department during the four years, and 40 systemic allergic reactions occurred, with the overall incidence rate of 0.22%. The incidence of systemic allergic reaction was 0.37% when using imported dust mite preparation and 0.15% when using domestic multi-component allergen preparation. The risk factors significantly related with SCIT-induced systemic allergic reactions in patients using imported dust mite preparation were age less than 18 years old (OR=3.186,95%CI: 1.255-8.085), highest injection concentration (OR value could not be calculated because all patients with systemic reactions were injected with highest concentration), and large local reaction in previous injection (OR=22.264,95%CI: 8.205-60.411). The risk factors for SCIT-induced systemic allergic reactions in patients using domestic allergen preparation were 5 or more types of allergens (OR=3.455,95%CI: 1.147-10.402), highest injection concentration (OR=3.794,95%CI: 1.226-11.740) and large local reaction in previous injection (OR=63.577,95%CI: 22.248-181.683). However, SCIT injection in pollen allergic patients during the pollen season did not show a correlation with systemic allergic reaction. Conclusion: The incidence of SCIT-induced systemic allergic reactions was low in the Chinese patient population of this study. Patients with one or more risk factors, such as multiple allergen injection, highest injection concentration, large local reaction in previous injection, should be given high attention and vigilance against systemic allergic reactions.
Collapse
Affiliation(s)
- L S Li
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730,China
| | - K Guan
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730,China
| | - J Yin
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730,China
| | - L L Wang
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730,China
| | - Y X Zhi
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730,China
| | - J L Sun
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730,China
| | - H Li
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730,China
| | - L P Wen
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730,China
| | - R Tang
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730,China
| | - J Q Gu
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730,China
| | - Z X Wang
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730,China
| | - L Cui
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730,China
| | - Y Y Xu
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730,China
| | - S N Bian
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730,China
| |
Collapse
|
5
|
Mao N, Xu YY, Zhang YX, Zhou H, Huang XB, Hou CL, Fan L. Phylogeny and species diversity of the genus Helvella with emphasis on eighteen new species from China. Fungal Syst Evol 2023; 12:111-152. [PMID: 38533478 PMCID: PMC10964050 DOI: 10.3114/fuse.2023.12.08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2023] [Accepted: 08/17/2023] [Indexed: 03/28/2024] Open
Abstract
Helvella is a widespread, frequently encountered fungal group appearing in forests, but the species diversity and molecular phylogeny of Helvella in China remains incompletely understood. In this work, we performed comprehensive phylogenetic analyses using multilocus sequence data. Six datasets were employed, including a five-locus concatenated dataset (ITS, nrLSU, tef1-α, rpb2, hsp), a two-locus concatenated dataset (ITS, nrLSU), and four single-locus datasets (ITS) that were divided based on the four different phylogenetic clades of Helvella recognized in this study. A total of I 946 sequences were used, of which 713 were newly generated, including 170 sequences of ITS, 174 sequences of nrLSU, 131 sequences of tef1-α, 107 sequences of rpb2 and 131 sequences of hsp. The phylogeny based on the five-locus concatenated dataset revealed that Helvellas. str. is monophyletic and four phylogenetic clades are clearly recognized, i.e., Acetabulum clade, Crispa clade, Elastica clade, and Lacunosa clade. A total of 24 lineages or subclades were recognized, II of which were new, the remaining 13 corresponding with previous studies. Chinese Helvella species are distributed in 22 lineages across four clades. Phylogenetic analyses based on the two-locus concatenated dataset and four single-locus datasets confirmed the presence of at least 93 phylogenetic species in China. Among them, 58 are identified as known species, including a species with a newly designated lectotype and epitype, 18 are newly described in this paper, and the remaining 17 taxa are putatively new to science but remain unnamed due to the paucity or absence of ascomatal materials. In addition, the Helvella species previously recorded in China are discussed. A list of 76 confirmed species, including newly proposed species, is provided. The occurrence of H. crispa and H. elastica are not confirmed although both are commonly recorded in China. Citation: Mao N, Xu YY, Zhang YX, Zhou H, Huang XB, Hou CL, Fan L (2023). Phylogeny and species diversity of the genus Helvella with emphasis on eighteen new species from China. Fungal Systematics and Evolution 12: 111-152. doi: 10.3114/fuse.2023.12.08.
Collapse
Affiliation(s)
- N Mao
- College of Life Science, Capital Normal University, Xisanhuanbeilu 105, Haidian, Beijing 100048, China
| | - Y Y Xu
- College of Life Science, Capital Normal University, Xisanhuanbeilu 105, Haidian, Beijing 100048, China
| | - Y X Zhang
- College of Life Science, Capital Normal University, Xisanhuanbeilu 105, Haidian, Beijing 100048, China
| | - H Zhou
- College of Life Science, Capital Normal University, Xisanhuanbeilu 105, Haidian, Beijing 100048, China
| | - X B Huang
- College of Life Science, Capital Normal University, Xisanhuanbeilu 105, Haidian, Beijing 100048, China
| | - C L Hou
- College of Life Science, Capital Normal University, Xisanhuanbeilu 105, Haidian, Beijing 100048, China
| | - L Fan
- College of Life Science, Capital Normal University, Xisanhuanbeilu 105, Haidian, Beijing 100048, China
| |
Collapse
|
6
|
Li HL, Sun JJ, Ma H, Liu SJ, Li N, Guo SJ, Shi Y, Xu YY, Qi ZY, Wang YQ, Wang F, Guo RM, Liu D, Xue FX. Erratum: [Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1. Oncol Lett 2023; 26:445. [PMID: 37720668 PMCID: PMC10502922 DOI: 10.3892/ol.2023.14032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/19/2023] Open
Abstract
[This corrects the article DOI: 10.3892/ol.2019.10694.].
Collapse
|
7
|
Qi ZY, Wang F, Yue YY, Guo XW, Guo RM, Li HL, Xu YY. Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo. J Ovarian Res 2023; 16:174. [PMID: 37626400 PMCID: PMC10463306 DOI: 10.1186/s13048-023-01267-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/27/2023] Open
Abstract
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13048-019-0593-2.
Collapse
Affiliation(s)
- Zhi-Ying Qi
- Department of Gynecolog, The Second Hospital of Tianjin Medical University, No.23 Pingjiang Road, Hexi District, Tianjin, 300211, China
| | - Fang Wang
- Department of Gynecolog, The Second Hospital of Tianjin Medical University, No.23 Pingjiang Road, Hexi District, Tianjin, 300211, China
| | - Ying-Ying Yue
- Department of Gynecolog, The Second Hospital of Tianjin Medical University, No.23 Pingjiang Road, Hexi District, Tianjin, 300211, China
| | - Xue-Wang Guo
- Department of Gynecolog, The Second Hospital of Tianjin Medical University, No.23 Pingjiang Road, Hexi District, Tianjin, 300211, China
| | - Rui-Meng Guo
- Department of Gynecolog, The Second Hospital of Tianjin Medical University, No.23 Pingjiang Road, Hexi District, Tianjin, 300211, China
| | - Hong-Lin Li
- Department of Gynecolog, The Second Hospital of Tianjin Medical University, No.23 Pingjiang Road, Hexi District, Tianjin, 300211, China
| | - Yan-Ying Xu
- Department of Gynecolog, The Second Hospital of Tianjin Medical University, No.23 Pingjiang Road, Hexi District, Tianjin, 300211, China.
| |
Collapse
|
8
|
Chen YS, Wang J, Ding LL, Xu YY, Zhang YH, Chen JG, Zhu J, Fan J. [Long-term trend analysis of liver cancer survival rate in Qidong region, Jiangsu Province, 1972-2019]. Zhonghua Gan Zang Bing Za Zhi 2023; 31:634-639. [PMID: 37400389 DOI: 10.3760/cma.j.cn501113-20220323-00133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Subscribe] [Scholar Register] [Indexed: 07/05/2023]
Abstract
Objective: To analyze the incidence and survival rate of liver cancer cases in the entire population in the Qidong region from 1972 to 2019, so as to provide a basis for prognosis evaluation, prevention, and treatment. Methods: The observed survival rate (OSR) and relative survival rate (RSR) of 34 805 cases of liver cancer in the entire Qidong region population from 1972 to 2019 were calculated using Hakulinen's method with SURV3.01 software. Hakulinen's likelihood ratio test was used for statistical analysis. Age-standardized relative survival (ARS) was calculated using the International Cancer Survival Standard. The Joinpoint regression analysis was performed with Joinpoint 4.7.0.0 software to calculate the average annual percentage change (AAPC) of the liver cancer survival rate. Results: 1-ASR increased from 13.80% in 1972-1977 to 50.20% in 2014-2019, while 5-ASR increased from 1.27% in 1972-1977 to 27.64% in 2014-2019. The upward trend of RSR over eight periods was statistically significant (χ (2) = 3045.29, P < 0.001). Among them, male 5-ASR was 0.90%, 1.80%, 2.33%, 4.92%, 5.43%, 7.05%, 10.78%, and 27.78%, and female 5-ASR was 2.33%, 1.51%, 3.35%, 3.92%, 3.84%, 7.18%, 11.45%, and 29.84%, respectively. There was a statistically significant difference in RSR between males and females (χ (2) = 45.68, P < 0.001). The 5-RSR for each age group of 25-34 years old, 35-44 years old, 45-54 years old, 55-64 years old, 65-74 years old, and 75 years old were 4.92%, 5.29%, 8.17%, 11.70%, 11.63%, and 9.60%, respectively. There were statistically significant differences in RSR among different age groups (χ (2) = 501.29, P < 0.001). The AAPC in Qidong region from 1972 to 2019 for 1-ARS, 3-ASR, and 5-ARS were 5.26% (t = 12.35, P < 0.001), 8.10% (t = 15.99, P < 0.001), and 8.96 % (t = 16.06, P < 0.001), respectively. The upward trend was statistically significant in all cases. The AAPC of 5-ARS was 9.82% in males (t = 14.14, P < 0.001), and 8.79% in females (t = 11.48, P < 0.001), and the upward trend was statistically significant in both. The AAPC of 25-34 years old, 35-44 years old, 45-54 years old, 55-64 years old, 65-74 years old, and 75 years old were 5.37% (t = 5.26, P = 0.002), 5.22% (t = 5.66, P = 0.001), 7.20% (t = 6.88, P < 0.001), 10.00% (t = 12.58, P < 0.001), 9.96% (t = 7.34, P < 0.001) and 8.83% (t = 3.51, P = 0.013), and the upward trend was statistically significant. Conclusion: The overall survival rate of registered cases of liver cancer in the Qidong region's entire population has greatly improved, but there is still much room for improvement. Hence, constant attention should be paid to the study on preventing and treating liver cancer.
Collapse
Affiliation(s)
- Y S Chen
- Department of Etiology, Qidong People's Hospital, the Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - J Wang
- Department of Etiology, Qidong People's Hospital, the Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - L L Ding
- Department of Etiology, Qidong People's Hospital, the Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - Y Y Xu
- Department of Etiology, Qidong People's Hospital, the Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - Y H Zhang
- Department of Etiology, Qidong People's Hospital, the Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - J G Chen
- Department of Etiology, Qidong People's Hospital, the Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - J Zhu
- Qidong Liver Cancer Institute, Qidong 226200, China
| | - J Fan
- Department of Etiology, Qidong People's Hospital, the Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| |
Collapse
|
9
|
Xu YY, Su ZZ, Zheng LM, Zhang MN, Tan JY, Yang YL, Zhang MX, Xu M, Chen N, Chen XQ, Zhou Q. [Read-through circular RNA rt-circ-HS promotes hypoxia inducible factor 1α expression and renal carcinoma cell proliferation, migration and invasiveness]. Beijing Da Xue Xue Bao Yi Xue Ban 2023; 55:217-227. [PMID: 37042131 PMCID: PMC10091263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 04/13/2023]
Abstract
OBJECTIVE To identify and characterize read-through RNAs and read-through circular RNAs (rt-circ-HS) derived from transcriptional read-through hypoxia inducible factor 1α (HIF1α) and small nuclear RNA activating complex polypeptide 1 (SNAPC1) the two adjacent genes located on chromosome 14q23, in renal carcinoma cells and renal carcinoma tissues, and to study the effects of rt-circ-HS on biological behavior of renal carcinoma cells and on regulation of HIF1α. METHODS Reverse transcription-polymerase chain reaction (RT-PCR) and Sanger sequencing were used to examine expression of read-through RNAs HIF1α-SNAPC1 and rt-circ-HS in different tumor cells. Tissue microarrays of 437 different types of renal cell carcinoma (RCC) were constructed, and chromogenic in situ hybridization (ISH) was used to investigate expression of rt-circ-HS in different RCC types. Small interference RNA (siRNA) and artificial overexpression plasmids were designed to examine the effects of rt-circ-HS on 786-O and A498 renal carcinoma cell proliferation, migration and invasiveness by cell counting kit 8 (CCK8), EdU incorporation and Transwell cell migration and invasion assays. RT-PCR and Western blot were used to exa-mine expression of HIF1α and SNAPC1 RNA and proteins after interference of rt-circ-HS with siRNA, respectively. The binding of rt-circ-HS with microRNA 539 (miR-539), and miR-539 with HIF1α 3' untranslated region (3' UTR), and the effects of these interactions were investigated by dual luciferase reporter gene assays. RESULTS We discovered a novel 1 144 nt rt-circ-HS, which was derived from read-through RNA HIF1α-SNAPC1 and consisted of HIF1α exon 2-6 and SNAPC1 exon 2-4. Expression of rt-circ-HS was significantly upregulated in 786-O renal carcinoma cells. ISH showed that the overall positive expression rate of rt-circ-HS in RCC tissue samples was 67.5% (295/437), and the expression was different in different types of RCCs. Mechanistically, rt-circ-HS promoted renal carcinoma cell proliferation, migration and invasiveness by functioning as a competitive endogenous inhibitor of miR-539, which we found to be a potent post-transcriptional suppressor of HIF1α, thus promoting expression of HIF1α. CONCLUSION The novel rt-circ-HS is highly expressed in different types of RCCs and acts as a competitive endogenous inhibitor of miR-539 to promote expression of its parental gene HIF1α and thus the proliferation, migration and invasion of renal cancer cells.
Collapse
Affiliation(s)
- Y Y Xu
- Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Z Z Su
- Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - L M Zheng
- Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - M N Zhang
- Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - J Y Tan
- Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
- Research Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Y L Yang
- Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - M X Zhang
- Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - M Xu
- Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - N Chen
- Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
- Research Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - X Q Chen
- Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
- Research Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Q Zhou
- Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
- Research Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China
| |
Collapse
|
10
|
Zheng H, Zhang JW, Zhang T, Liu YG, Jiang ST, Zhang YS, Zhang L, Xu YY, Zhao HT, Lu X, Sang XT. [Application of augmented reality navigation in laparoscopic and robot-assisted liver surgery]. Zhonghua Wai Ke Za Zhi 2023; 61:431-436. [PMID: 36987677 DOI: 10.3760/cma.j.cn112139-20221012-00435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 03/30/2023]
Abstract
In recent years, laparoscopic surgery and robotic surgery have been widely used, and various intraoperative image navigation systems have also developed rapidly. However, the liver itself has a complex vessel and duct system, which increase the difficulty of liver surgery. The augmented reality image navigation system combines the three-dimensional reconstructed image of the liver with the real liver anatomy, which presents the specific relationship between the tumor location and the surrounding vessels for the surgeon. Compared with other intraoperative image navigation methods, augmented reality has its unique advantages. This paper provides an overview of current advances in registration technology in augmented reality image navigation system, and focuses on its applications in liver surgery, including laparoscopic surgery and robotic surgery. Finally, the technological problems and difficulties still faced at present are summarized, and future directions worth studying in this field are proposed.
Collapse
Affiliation(s)
- H Zheng
- Department of Liver Surgery, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, Beijing 100730, China
| | - J W Zhang
- Department of Liver Surgery, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, Beijing 100730, China
| | - T Zhang
- Department of Liver Surgery, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Y G Liu
- Department of Liver Surgery, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, Beijing 100730, China
| | - S T Jiang
- Department of Liver Surgery, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Y S Zhang
- Department of Liver Surgery, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, Beijing 100730, China
| | - L Zhang
- Department of Liver Surgery, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Y Y Xu
- Department of Liver Surgery, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, Beijing 100730, China
| | - H T Zhao
- Department of Liver Surgery, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, Beijing 100730, China
| | - X Lu
- Department of Liver Surgery, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, Beijing 100730, China
| | - X T Sang
- Department of Liver Surgery, Peking Union Medical College Hospital, Peking Union Medical College,Chinese Academy of Medical Sciences, Beijing 100730, China
| |
Collapse
|
11
|
Yuan YH, Xu PP, Xu YY, Liu S, Shao XY, Zhang WJ, Gong L, Zhou M, Chen B, Zhou RF. [Analysis of the effects of low/intermediate dose of coagulation factor Ⅷ on 30 adult patients with severe hemophilia A in a single center]. Zhonghua Xue Ye Xue Za Zhi 2023; 44:38-42. [PMID: 36987721 PMCID: PMC10067379 DOI: 10.3760/cma.j.issn.0253-2727.2023.01.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 03/30/2023]
Abstract
Objective: To evaluate the clinical effects of low- and intermediate-dose factor Ⅷ (F Ⅷ) prophylaxis in Chinese adult patients with severe hemophilia A. Methods: Thirty adult patients with severe hemophilia A who received low- (n=20) /intermediate-dose (n=10) F Ⅷ prophylaxis at Nanjing Drum Tower Hospital affiliated with Nanjing University Medical College were included in the study. The annual bleeding rate (ABR), annual joint bleeding rate (AJBR), number of target joints, functional independence score of hemophilia (FISH), quality of life score, and health status score (SF-36) before and after preventive treatment were retrospectively analyzed and compared. Results: The median follow-up was 48 months. Compared with on-demand treatment, low- and intermediate-dose prophylaxis significantly reduced ABR, AJBR, and the number of target joints (P<0.05) ; the improvement in the intermediate-dose prophylaxis group was better than that in the low-dose prophylaxis group (P<0.05). Compared with on-demand treatment, the FISH score, quality of life score, and SF-36 score significantly improved in both groups (P<0.05), but there was no significant difference between the two groups (P>0.05) . Conclusion: In Chinese adults with severe hemophilia A, low- and intermediate-dose prophylaxis can significantly reduce bleeding frequency, delay the progression of joint lesions, and improve the quality of life of patients as compared with on-demand treatment. The improvement in clinical bleeding was better with intermediate-dose prophylaxis than low-dose prophylaxis.
Collapse
Affiliation(s)
- Y H Yuan
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - P P Xu
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - Y Y Xu
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - S Liu
- Department of Ultrasound, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - X Y Shao
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - W J Zhang
- Department of Ultrasound, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - L Gong
- Department of Ultrasound, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - M Zhou
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - B Chen
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - R F Zhou
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| |
Collapse
|
12
|
Huang PH, Duan XB, Tang ZZ, Zou ZX, Song WM, Gao G, Li D, Nie FQ, Yan X, Fu YX, Guo R, Xu YY. Betulinaldehyde exhibits effective anti-tumor effects in A549 cells by regulating intracellular autophagy. Sci Rep 2023; 13:743. [PMID: 36639415 PMCID: PMC9839726 DOI: 10.1038/s41598-023-27580-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2022] [Accepted: 01/04/2023] [Indexed: 01/15/2023] Open
Abstract
It is of great significance to find new effective drugs for an adjuvant therapy targeting lung cancer to improve the survival rate and prognosis of patients with the disease. Previous studies have confirmed that certain Chinese herbal extracts have clear anti-tumor effects, and in our preliminary study, betulinaldehyde was screened for its potential anti-tumor effects. The current study thus aimed to confirm the anti-tumor effect of betulinaldehyde, using in vitro experiments to explore its underlying molecular mechanism. It was found that betulinaldehyde treatment significantly inhibited the viability, proliferation, and migration of A549 cells in a dose-dependent manner. In addition, betulinaldehyde inhibited the activation of Akt, MAPK, and STAT3 signaling pathways in A549 cells in a time-dependent manner. More importantly, betulinaldehyde also decreased the expression level of SQSTM1 protein, increased the expression level of LC3 II, and increased the autophagy flux in A549 cells. The pretreatment of A549 cells with the autophagy inhibitor, 3-methyladenine, could partially negate the anti-tumor effects of betulinaldehyde. These findings suggest that betulinaldehyde could significantly inhibit the oncological activity of A549 cells by regulating the intracellular autophagy level, making it a potentially effective option for the adjuvant therapy used to treat lung cancer in the future.
Collapse
Affiliation(s)
- Pan-Hao Huang
- Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China
| | - Xiang-Bing Duan
- Department of Laboratory Medicine, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.,Department of Medical Laboratory Science, Xiangya Medical School, Central South University, Changsha, 410013, Hunan, China
| | - Zi-Zhao Tang
- Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China
| | - Zhen-Xing Zou
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410078, Hunan, China
| | - Wen-Min Song
- Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China
| | - Ge Gao
- Department of Laboratory Medicine, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.,Department of Medical Laboratory Science, Xiangya Medical School, Central South University, Changsha, 410013, Hunan, China
| | - Dai Li
- Phase I Clinical Research Center, Xiangya Hospital, Central South University, Changsha, 410005, Hunan, China
| | - Fang-Qin Nie
- Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China
| | - Xin Yan
- Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China
| | - Yang-Xia Fu
- Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China
| | - Ren Guo
- Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. .,Center of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.
| | - Yan-Ying Xu
- Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
| |
Collapse
|
13
|
Xu YY, Li YY, Chen QL, Ma HM, Zhang J, Guo S. [A case of primary pigmented nodular adrenocortical disease caused by somatic variation of the PRKACA gene]. Zhonghua Er Ke Za Zhi 2023; 61:76-78. [PMID: 36594126 DOI: 10.3760/cma.j.cn112140-20220626-00589] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Affiliation(s)
- Y Y Xu
- Department of Pediatrics, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China
| | - Y Y Li
- Department of Pediatrics, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China
| | - Q L Chen
- Department of Pediatrics, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China
| | - H M Ma
- Department of Pediatrics, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China
| | - J Zhang
- Department of Pediatrics, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China
| | - S Guo
- Department of Pediatrics, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China
| |
Collapse
|
14
|
Jiang MB, Chen YS, Wang J, Xu YY, Ding LL, Zhang YH, Chen JG, Zhu J. [Long-term trend of colorectal cancer survival rate in Qidong, 1972-2016]. Zhonghua Zhong Liu Za Zhi 2022; 44:1357-1361. [PMID: 36575787 DOI: 10.3760/cma.j.cn112152-20220308-00159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Objective: The survival of colorectal cancer in Qidong City, Jiangsu Province from 1972 to 2016 was analyzed to provide a basis for the evaluation of prognosis and the formulation of prevention and control measures. Methods: Colorectal cancer data were obtained from the Qidong Cancer Registration and Reporting System, and the follow-up was up to December 31, 2021. The observed survival rate (OSR) and relative survival rate (RSR) were calculated by SURV 3.01 software, and the trend test was performed by Hakulinen's likelihood ratio test. The Joinpoint regression model was used to calculate the average annual percentage change (AAPC) of survival, and the ARIMA model was used to predict the trend of colorectal cancer survival. Results: There were 8 637 new cases of colorectal cancer in Qidong from 1972 to 2016. Dividing 1972-2016 into 9 periods at 5-year intervals, the 5-year OSR from 1972-1976 to 2012-2016 increased from 21.86% to 48.86%, and the 5-year RSR increased from 26.45% to 59.91%. The increasing trend of RSR was statistically significant (χ(2)=587.47, P<0.001). From 1972 to 2016, the survival rates of colorectal cancer in different sexes in Qidong were similar, and the 5-year RSR was 44.63% for men and 44.07% for women. Since the 1990s, the 5-year OSR and RSR for men have been lower than those for women. From 1972 to 2016, the 5-year RSR of colorectal cancer in Qidong was significantly improved in the 65-74 and ≥75-year-old groups, but the survival rate of the ≥75-year-old group was still the lowest (36.78%), followed by the 35-44-year-old group ( 43.04%). The time trend showed that the overall AAPC of colorectal cancer 5-year RSR in Qidong from 1972 to 2016 was 2.50% (t=16.45, P<0.001). The upward trend of different sexes was consistent, and the increase was greater in women (AAPC for males=2.18%, AAPC for females=2.54%, both P<0.05). The 5-year RSR of colorectal cancer in each age group showed an upward trend, and the AAPCs of the 35-44, 45-54, 55-64, 65-74, and ≥75-year-old groups were 1.54%, 1.83%, 2.00%, 3.51% and 4.35%, respectively (all P<0.05). The prediction results of colorectal cancer survival rate showed that the 5-year RSR of colorectal cancer in Qidong will increase to 71.62% by 2026. Conclusions: The overall survival rate of colorectal cancer patients in Qidong has been greatly improved, but there is still room for improvement. We should continue to pay attention to the early diagnosis and early treatment of colorectal cancer.
Collapse
Affiliation(s)
- M B Jiang
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - Y S Chen
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - J Wang
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - Y Y Xu
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - L L Ding
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - Y H Zhang
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - J G Chen
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - J Zhu
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| |
Collapse
|
15
|
Wang J, Chen YS, Ding LL, Zhang YH, Xu YY, Chen JG, Zhu J. [Long-term trend of esophageal cancer survival rate in Qidong, 1972-2016]. Zhonghua Zhong Liu Za Zhi 2022; 44:1091-1095. [PMID: 36319454 DOI: 10.3760/cma.j.cn112152-20220307-00156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
Objective: To analyze the survival of esophageal cancer cases in Qidong, Jiangsu Province from 1972 to 2016, and provide a basis for the prognosis evaluation and prevention of esophageal cancer patients. Methods: The data of esophageal cancer were obtained from the Qidong Cancer Registration and Reporting System, and the follow-up date ended December 31, 2021. Observed survival rate (OSR) and relative survival rate (RSR) were calculated by SURV 3.01 software, and Hakulinen's likelihood ratio test was used for statistical difference comparison. Joinpoint regression model was used to conduct the average annual percentage change (AAPC) in esophageal cancer survival rate, and the ARIMA model was used to predict the trend of esophageal cancer survival rate. Results: During 1972 to 2016, there were 5 112 new cases of esophageal cancer in Qidong. The OSR of esophageal cancer at 1, 5 and 10 years were 24.43%, 6.93% and 4.43%, and the RSR at 1, 5 and 10 years were 25.88%, 9.35% and 8.34%, respectively. Dividing 1972-2016 into 9 periods, compared with 1972-1976, the 5-year RSR from 2012-2016 increased from 4.47% to 17.85%, and the RSR trend of the 9 periods was statistically significant (χ(2)=263.43, P<0.001). The survival rate of female with esophageal cancer was slightly higher than that of male, however, there was no significant difference in RSR between male and female (χ(2)=9.40, P=0.401). The 5-OSR and 5-RSR for male were 6.73% and 9.11%, and for female were 7.37% and 9.87%, respectively. The 5-RSR for the age groups of 45-54, 55-64, 65-74, and over 75 years old were 11.99%, 11.21%, 8.17% and 7.08%, respectively. There was a statistically significant difference in RSR among different age groups (χ(2)=98.19, P<0.001). The time trend results showed that the overall AAPC of the 5-RSR of esophageal cancer in Qidong from 1972 to 2016 was 3.89% (t=11.98, P<0.001). The 5-RSR uptrend was consistent among different genders, and the uptrend was greater in female (AAPC=4.25% for male, and AAPC=5.72% for female, P<0.05). Furthermore, the 5-RSR of esophageal cancer in all age groups showed an upward trend, and the upward trend was statistically significant in the 55-64-year-old group (AAPC=4.23%, P<0.05) and the 65-74-year-old group (AAPC=6.82%, P<0.05), there was no statistical significance in the 45-54-year-old group (AAPC=2.17%, P>0.05) and more than 75 years old group (AAPC=1.82%, P>0.05). Survival rate prediction of esophageal cancer showed that by 2026, 5-RSR will increase to 24.79%. Conclusions: During 1972 to 2016, the overall survival rate of esophageal cancer in the whole population of Qidong has improved to a certain extent, but there is still a large room for improvement. More emphasis should be continued to strengthen on the early diagnosis and early treatment of esophageal cancer.
Collapse
Affiliation(s)
- J Wang
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - Y S Chen
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - L L Ding
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - Y H Zhang
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - Y Y Xu
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - J G Chen
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - J Zhu
- Department of Etiology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| |
Collapse
|
16
|
Pan ZX, Xu YY, Bian SN, Li J, Jiang YL, Li J, Guan K. [Progress on the diagnosis and therapy about atopic diseases and primary immunodeficiency diseases]. Zhonghua Yu Fang Yi Xue Za Zhi 2022; 56:1218-1225. [PMID: 36207883 DOI: 10.3760/cma.j.cn112150-20220523-00518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
Primary immunodeficiency diseases (PID) is a congenital disease caused by single gene germline mutation related to the immune system. PID patients have immune dysregulation, and are susceptible to infectious diseases, autoimmune diseases, autoimmune diseases, allergic diseases, and malignant tumors. The first symptom of some PID patients is atopic disease, therefore they go to the department of allergy, department of pediatrics and other relevant departments. How to identify and diagnose PID in allergic patients, to reduce diagnosis delay and prevent disease aggravation are the abilities that allergists, pediatricians, and doctors in other relevant departments need to master. This article summarizes the warning signs of PID in allergic patients and the mechanism of allergy combined with PID, and then summarizes the common types of PID in allergic patients, the evaluation, treatment and prevention in patients with PID and allergy.
Collapse
Affiliation(s)
- Z X Pan
- Department of Allergy, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730, China
| | - Y Y Xu
- Department of Allergy, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730, China
| | - S N Bian
- Department of Allergy, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730, China
| | - J Li
- Department of Pediatrics, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Y L Jiang
- Department of Gynaecology and Obstetrics, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - J Li
- Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - K Guan
- Department of Allergy, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing 100730, China
| |
Collapse
|
17
|
Fan L, Li T, Xu YY, Yan XY. Species diversity, phylogeny, endemism and geography of the truffle genus Tuber in China based on morphological and molecular data. Persoonia 2022; 48:175-202. [PMID: 38234690 PMCID: PMC10792285 DOI: 10.3767/persoonia.2023.48.05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Figures] [Subscribe] [Scholar Register] [Received: 03/22/2021] [Accepted: 03/18/2022] [Indexed: 01/19/2024]
Abstract
The genus Tuber (Tuberaceae, Pezizales) is an important fungal group of Ascomycota both economically and ecologically. However, the species diversity, phylogenetic relationships, and geographic distribution of Tuber species in China remains poorly understood, primarily because descriptions of many new species relied heavily on morphological features with molecular data either not sought or ignored. The misapplication of European and North American names further added to confusion regarding the taxonomy of Chinese Tuber species. In this study, we examined more than 1 000 specimens from China, and performed a comprehensive phylogenetic analysis for Chinese Tuber species using ITS sequences and multilocus sequence data. To infer the phylogeny of Chinese Tuber spp., 11 molecular datasets were assembled, including a concatenated internal transcribed spacers of the nuc rDNA (ITS), nuc rDNA 28S subunit (LSU), translation elongation factor 1-alpha (tef1-α), and RNA polymerase II subunit (rpb2) dataset as well as 10 ITS datasets (totally including 1 435 sequences from 828 collections with 597 newly generated sequences, and 168 sequences from the types of 63 species). Our phylogenetic tree based on a concatenated multilocus dataset revealed that all Chinese Tuber species nested in nine phylogenetic clades (phylogroups), including Aestivum, Excavatum, Latisporum, Macrosporum, Maculatum, Melanosporum, Puberulum, Rufum and Turmericum. Of these, five phylogroups (Macrosporum, Maculatum, Melanosporum, Puberulum and Rufum) are shared across the continents of Asia, Europe and North America; two phylogroups (Aestivum and Excavatum) are shared by Europe and Asia; and the phylogroups Turmericum and Latisporum are endemic only to Asia. Phylogenetic trees based on 10 ITS datasets confirmed the presence of at least 82 phylogenetic species in China. Of these, 53 are identified as known species, including three new records for China, and 25 species are identified as new to science. Of the new species, nine are described and illustrated in this paper, and the others remain unnamed due to the paucity or absence of ascomatal materials. Accordingly, the confirmed, excluded and doubtful Tuber species in China are discussed. Tuber species showed high endemism. Of the 82 phylogenetic species found in China, 68 species occur only in China, six species are also found in other regions in Asia, and only eight species (T. anniae, T. excelsum-reticulatum, T. formosanum, T. maculatum, T. wenchuanense, Tuber sp. CHN-3, Tuber sp. CHN-10 and Tuber sp. CHN-11) are shared with other continents. Most Tuber species have a small and limited distribution in China, but a few, such as T. formosanum and T. parvomurphium, are widely distributed across China. Some phylogenetically closely related species, such as T. liaotongense and T. subglobosum, as well as T. xuanhuaense and T. lijiangense, show a pattern of allopatric distribution.
Collapse
Affiliation(s)
- L Fan
- College of Life Science, Capital Normal University, Xisanhuanbeilu 105, Haidian, Beijing 100048, China
- College of Life Science, Capital Normal University, Xisanhuanbeilu 105, Haidian, Beijing 100048, China
| | - T Li
- College of Life Science, Capital Normal University, Xisanhuanbeilu 105, Haidian, Beijing 100048, China
- College of Life Science, Capital Normal University, Xisanhuanbeilu 105, Haidian, Beijing 100048, China
| | - Y Y Xu
- College of Life Science, Capital Normal University, Xisanhuanbeilu 105, Haidian, Beijing 100048, China
| | - X Y Yan
- College of Life Science, Capital Normal University, Xisanhuanbeilu 105, Haidian, Beijing 100048, China
| |
Collapse
|
18
|
Sheng Y, Zhao XL, Xu YY, Jin DQ. [Fulminant myocarditis caused by severe fever with thrombocytopenia syndrome bunyavirus in a child]. Zhonghua Er Ke Za Zhi 2022; 60:717-718. [PMID: 35768364 DOI: 10.3760/cma.j.cn112140-20211122-00977] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Affiliation(s)
- Y Sheng
- Department of Pediatric Intensive Care Unit, Anhui Provincial Children's Hospital, Hefei 230051, China
| | - X L Zhao
- Department of Pediatric Intensive Care Unit, Anhui Provincial Children's Hospital, Hefei 230051, China
| | - Y Y Xu
- Department of Pediatric Intensive Care Unit, Anhui Provincial Children's Hospital, Hefei 230051, China
| | - D Q Jin
- Department of Pediatric Intensive Care Unit, Anhui Provincial Children's Hospital, Hefei 230051, China
| |
Collapse
|
19
|
Peng RZ, Li ZZ, Xu YY. [Advances on the toxicology and molecular mechanisms of different components of ambient fine particulate matter]. Zhonghua Yu Fang Yi Xue Za Zhi 2022; 56:645-651. [PMID: 35644981 DOI: 10.3760/cma.j.cn112150-20210516-00471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Ambient fine particulate matters (PM2.5) refer to particulate matters with an aerodynamic diameter less than or equal to 2.5 μm. PM2.5 enter the body through the target organ-lung, and can induce a variety of adverse health effects (such as cardiovascular diseases, diabetes, respiratory diseases, neurodegenerative diseases and adverse birth outcomes). PM2.5 are known to have complex compositions (including water-soluble/-insoluble components and biological components), diverse sources and capacity of secondary transformation. Numerous epidemiological and toxicological studies indicated that different components of PM2.5 may induce adverse health effects through different biological mechanisms. In adddition, co-exposure of different components and their interaction should also be considered. Thus here we have systematically reviewed studies in recent years about the toxicological effects and underlying mechanisms of different components of ambient fine particulate matters, including inflammatory response, oxidative stress, endoplasmic reticulum stress, activation of the NF-κB signaling pathway and so on. The information may give some insights into the prevention and treatment of adverse health effects caused by exposure to different components of PM2.5.
Collapse
Affiliation(s)
- R Z Peng
- Department of Environmental Health, School of Public Health, Fudan University, Shanghai 200032, China
| | - Z Z Li
- Department of Environmental Health, School of Public Health, Fudan University, Shanghai 200032, China
| | - Y Y Xu
- Department of Environmental Health, School of Public Health, Fudan University, Shanghai 200032, China
| |
Collapse
|
20
|
Xu YY, Zhang JT, Xu M, Liu DM, Ding JP, Pei DL, Hong QC. First Report of Powdery Mildew Caused by Golovinomyces monardae on Scarlet Beebalm ( Monarda didyma) in China. Plant Dis 2022; 106:1525. [PMID: 34763518 DOI: 10.1094/pdis-08-21-1803-pdn] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Affiliation(s)
- Y Y Xu
- Henan Academician Workstation for Industrial Technology of Dry Chili, Key Laboratory of Plant-Microbe Interactions, School of Biology and Food, Shangqiu Normal University, Shangqiu 476000, China
| | - J T Zhang
- Henan Academician Workstation for Industrial Technology of Dry Chili, Key Laboratory of Plant-Microbe Interactions, School of Biology and Food, Shangqiu Normal University, Shangqiu 476000, China
| | - M Xu
- Henan Academician Workstation for Industrial Technology of Dry Chili, Key Laboratory of Plant-Microbe Interactions, School of Biology and Food, Shangqiu Normal University, Shangqiu 476000, China
| | - D M Liu
- Henan Academician Workstation for Industrial Technology of Dry Chili, Key Laboratory of Plant-Microbe Interactions, School of Biology and Food, Shangqiu Normal University, Shangqiu 476000, China
| | - J P Ding
- Henan Academician Workstation for Industrial Technology of Dry Chili, Key Laboratory of Plant-Microbe Interactions, School of Biology and Food, Shangqiu Normal University, Shangqiu 476000, China
| | - D L Pei
- Henan Academician Workstation for Industrial Technology of Dry Chili, Key Laboratory of Plant-Microbe Interactions, School of Biology and Food, Shangqiu Normal University, Shangqiu 476000, China
| | - Q C Hong
- Henan Academician Workstation for Industrial Technology of Dry Chili, Key Laboratory of Plant-Microbe Interactions, School of Biology and Food, Shangqiu Normal University, Shangqiu 476000, China
| |
Collapse
|
21
|
Chen YS, Zhu J, Wang J, Ding LL, Zhang YH, Xu YY, Chen JG. [Epidemic characteristics of stomach cancer mortality in Qidong during 1972-2016]. Zhonghua Zhong Liu Za Zhi 2022; 44:99-103. [PMID: 35073655 DOI: 10.3760/cma.j.cn112152-20200905-00797] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Objective: To describe the epidemic characteristics of stomach cancer mortality in Qidong between 1972 and 2016. Methods: The cancer registry data of stomach cancer death and population during 1972-2016 in Qidong was collected. The mortality of crude rate (CR), China age-standardized rate (CASR), world age-standardized rate (WASR), 35-64 years truncated rate, 0-74 years cumulative rate, cumulative risk, percentage change (PC), annual percent change (APC) were calculated. Results: During 1972-2016, a total of 15 863 (male: 10 114, female: 5 749) deaths occurred attributed to stomach cancer, accounting for 16.04% of all cancers, with CR of 31.37/100 000 (CASR: 12.97/100 000, WASR: 21.39/100 000). The truncated rate of 35-64, cumulative rate of 0-74, and cumulative risk were 28.86/100 000, 2.54%, and 2.51%, respectively. For male, the CR, CASR, WASR were 40.53/100 000, 17.98/100 000, 30.13/100 000, respectively, and for female, the CR, CASR, WASR were 22.45/100 000, 8.52/100 000, 13.92/100 000, respectively. Age-specific mortality analysis showed that the mortality of each age group under 25-year-old group was less than 1/100 000. The CR increased with age. The 50-year-old group reached and exceeded the average mortality of the population, and more than 80-year-old group reached the peak of death. During 1972-2016 in Qidong, The PCs in CR, CASR, and WASR of stomach cancer were 55.43%, -52.02%, -43.60%. The APC were 0.54%, -2.30%, -2.08%, respectively. Period mortality analysis showed that except for the 75-year-old group, the mortality of stomach cancer decreased significantly. Conclusions: The crude mortality of stomach cancer increases slightly in Qidong, while the CASR and WASR decrease significantly. However, stomach cancer is still one of the malignant tumors that most affect health and seriously threat lives.
Collapse
Affiliation(s)
- Y S Chen
- Epidemiology Research Office, Qidong Hospital Affiliated Nantong University, Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong 226200, China
| | - J Zhu
- Epidemiology Research Office, Qidong Hospital Affiliated Nantong University, Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong 226200, China
| | - J Wang
- Epidemiology Research Office, Qidong Hospital Affiliated Nantong University, Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong 226200, China
| | - L L Ding
- Epidemiology Research Office, Qidong Hospital Affiliated Nantong University, Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong 226200, China
| | - Y H Zhang
- Epidemiology Research Office, Qidong Hospital Affiliated Nantong University, Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong 226200, China
| | - Y Y Xu
- Epidemiology Research Office, Qidong Hospital Affiliated Nantong University, Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong 226200, China
| | - J G Chen
- Epidemiology Research Office, Qidong Hospital Affiliated Nantong University, Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong 226200, China
| |
Collapse
|
22
|
Li KD, Xu YY, Guo CL, Pu Q, Mei JD, Liu CW, Zhu YK, Liu LX. [Emulation pulmonary nodules localization model:a novel non-invasive localization technique in resection of pulmonary nodules]. Zhonghua Yi Xue Za Zhi 2021; 101:3966-3972. [PMID: 34955000 DOI: 10.3760/cma.j.cn112137-20211020-02321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Objective: To explore the accuracy and efficiency of a novel 3D-printed emulation localization model of small pulmonary nodules in lung surgery. Methods: From April 2020 to April 2021, a total of 66 patients were selected in the study, who underwent localization and resection of pulmonary nodules with video-assisted thoracoscopic surgery (VATS) guided by the 3D-printed emulation localization model at Department of Thoracic Surgery, West China Hospital of Sichuan University. There were 13 males and 53 females, aged from 25 to 79 (52.7±11.4) years. Of all patients, 24 (36.4%) had single pulmonary nodule, and 42 (63.6%) had synchronous multiple pulmonary nodules. The chest high-resolution CT image data were utilized for digital reconstruction and 3D printing to make a tailored life-size emulation pulmonary nodules localization model, which was used to navigate real-time intraoperative localization of nodules. Clinical data including operative parameters, localization information, resection types and pathological findings of nodules were analyzed. The pulmonary nodules that doctors planned to resect were categorized into two categories:major nodules and additional nodules, according to their presence of invasion and radiological risk factors. The accuracy of localization and resection efficiency of nodules were evaluated in accordance with the categories of the nodules respectively. Results: On the basis of preoperative evaluation, there were 71 major nodules with median maximal diameter of 0.9 (0.6-1.3) cm, and 77 additional nodules with median maximal diameter of 0.5 (0.4-0.7) cm. All patients underwent VATS surgery, 52 of them (78.8%) were treated with uniportal VATS and 14 (21.2%) with triportal VATS. Among the patients with single nodule, 18 segmentectomies and 6 wedge resections were performed; whereas among the patients with multiple nodules, 5 segmentectomies, 14 wedge resections, and 23 combined pulmonary resections (including 2 cases of lobectomy+segmentectomy, 7 cases of lobectomy+wedge resections, and 14 cases of segmentectomy+wedge resections) were achieved. The median operative time was 93 (45-240) min, and the median resection time for all nodules was 51.4 (6.7-147.0) min. All major nodules were successfully resected and visibly dissected after removal, and all additional nodules were successfully resected with 85.7%(66/77) nodules visibly dissected. The accuracy rate of localization of both types of nodules was 100%. All major nodules were malignant, and the malignancy rate of additional nodules was 21.2%(14/66). Conclusion: This novel 3D-printed emulation localization model of small pulmonary nodules proved to be a non-invasive, accurate and efficient technique. Not only that, it has a unique advantage in localization of synchronous multiple pulmonary nodules.
Collapse
Affiliation(s)
- K D Li
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Y Y Xu
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - C L Guo
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Q Pu
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - J D Mei
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - C W Liu
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Y K Zhu
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - L X Liu
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| |
Collapse
|
23
|
Chen YS, Wang J, Ding LL, Zhang YH, Xu YY, Chen JG, Zhu J. [An analysis of mortality trends for upper gastrointestinal neoplasms in Qidong, 1972-2016]. Zhonghua Zhong Liu Za Zhi 2021; 43:1228-1234. [PMID: 34915629 DOI: 10.3760/cma.j.cn112152-20210329-00273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To describe the trend of upper gastrointestinal cancer mortality in Qidong between 1972 and 2016, and to provide guidelines for prevention and control measures and strategies. Methods: The upper gastrointestinal data was collected in Qidong cancer registration from 1972 to 2016. Crude mortality rate (CR), China age-standardized rate (CASR), world age-standardized rate (WASR), truncated rate (35-64 years old), cumulative rate (0-74 years old) and cumulative risk were calculated. Annual percent change (APC) was calculated by Joinpoint software. Age-period-cohort model was used to analyze the influence of age, period and birth cohort on the changes in the mortality trend of upper gastrointestinal cancer patients. Results: From 1972 to 2016, there were 20 658 deaths of upper gastrointestinal cancer in Qidong, accounting for 20.89% of all cancer deaths. The CR, CASR, WASR, truncated rate (35-64 years old), cumulative rate (0-74 years old) and cumulative risk were 40.85/100 000, 27.96/100 000, 27.69/100 000, 36.01/100 000, 3.30% and 3.25%, respectively. There were 13 429 male deaths, the CR, CASR, and the WASR were 53.81/100 000, 37.62/100 000, and 39.93/100 000; the female deaths were 7 229, and the CR, CASR, and WASR were 28.23/100 000, 18.87/100 000, 17.25/100 000, respectively. The APCs of the 45-year-old, 55-year-old and 65-year-old age groups were -2.94% (95% CI: -3.32%, -2.56%), -2.94% (95% CI: -3.22%, -2.66%) and -2.04% (95% CI: -2.39%, -1.69%), with significant difference (P<0.05), while without significance of 75-year-old group (P>0.05). From 1972 to 2016, the APCs of CR, CASR, and WASR in the gastrointestinal cancer were 0.65% (95%CI: 0.43%, 0.87%), -2.01% (95%CI: -2.24%, -1.77%) and -2.05% (95%CI: -2.28%, -1.81%). The age-period-cohort model showed that the mortality of upper gastrointestinal cancer was increased with age (P<0.05). Conclusions: The crude mortality of upper gastrointestinal cancer increases slightly in Qidong, while the CASR and WASR decrease significantly. However, with aged tendency of population, the early diagnosis and treatment of upper gastrointestinal cancer is still needed to be paid attention.
Collapse
Affiliation(s)
- Y S Chen
- Epidemiological Research Office, Qidong Hospital Affiliated Nantong University, Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong 226200, China
| | - J Wang
- Epidemiological Research Office, Qidong Hospital Affiliated Nantong University, Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong 226200, China
| | - L L Ding
- Epidemiological Research Office, Qidong Hospital Affiliated Nantong University, Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong 226200, China
| | - Y H Zhang
- Epidemiological Research Office, Qidong Hospital Affiliated Nantong University, Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong 226200, China
| | - Y Y Xu
- Epidemiological Research Office, Qidong Hospital Affiliated Nantong University, Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong 226200, China
| | - J G Chen
- Epidemiological Research Office, Qidong Hospital Affiliated Nantong University, Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong 226200, China
| | - J Zhu
- Epidemiological Research Office, Qidong Hospital Affiliated Nantong University, Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong 226200, China
| |
Collapse
|
24
|
Xu YY, Qin F, Dai YX, Zhong XF, Yan J, Xu SM, Xu PS. Method development and validation of sildenafil, N-desmethylsildenafil and N1,N4-desmethylsildenafil by LC-MS/MS and its application. Anal Biochem 2021; 631:114355. [PMID: 34461080 DOI: 10.1016/j.ab.2021.114355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2021] [Revised: 08/19/2021] [Accepted: 08/21/2021] [Indexed: 11/19/2022]
Abstract
This study aimed to develop an LC-MS/MS method for determining sildenafil and its metabolites N-desmethylsildenafil and N1,N4-desmethylsildenafil in human plasma and applying it to a pharmacokinetic study of sildenafil in healthy volunteers. Sildenafil-d8 was used as the internal standard. Plasma samples were pretreated via protein precipitation with acetonitrile. The extractives were then separated on an ACQUITY UPLC BEH C18 (50-mm × 2.1-mm, 1.7-μm) column using gradient elution. The aqueous and organic mobile phases were ammonium formate 2 mM supplemented with 0.1% formic acid in water and acetonitrile, respectively, and the flow rate was 0.3 mL/min. An electrospray ionization source was applied, and multiple reaction monitoring was operated in the positive mode with selective channels at m/z 475.30 → 100.10, 461.20 → 283.30, 483.30 → 108.10, and 449.00 → 283.00 for sildenafil, sildenafil-d8, N-desmethylsildenafil, and N1,N4-desmethylsildenafil, respectively. The linear calibration curves of sildenafil and its metabolites spanned 1.0-1000 ng/mL. The lower limit of quantification was 1.0 ng/mL. The extractive recovery of analytes from the biological matrix was more than 90% and the matrix effect complied with relevant provisions. The intra- and inter-day precisions of sildenafil and its metabolite were <10%. The intra- and inter-day accuracy of sildenafil, N-desmethylsildenafil, and N1,N4-desmethylsildenafil was more than 99%. The method is highly sensitive and selective, and it was successfully applied to the bioequivalence studies of 100-mg sildenafil citrate tablets in 40 healthy Chinese volunteers.
Collapse
Affiliation(s)
- Yan-Ying Xu
- Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, 410008, PR China
| | - Fei Qin
- GuangZhou BAIYUNSHAN Pharmaceutical HOLDINGS CO., LTD., BAIYUNSHAN Pharmaceutical General Factory, Guangzhou, 510515, PR China
| | - Yi-Xin Dai
- Phase Ⅰ Clinical Trial Research Center, Xiangya Hospital, Central South University, Changsha, 410008, PR China
| | - Xue-Feng Zhong
- Phase Ⅰ Clinical Trial Research Center, Xiangya Hospital, Central South University, Changsha, 410008, PR China
| | - Juan Yan
- Phase Ⅰ Clinical Trial Research Center, Xiangya Hospital, Central South University, Changsha, 410008, PR China
| | - Su-Mei Xu
- Phase Ⅰ Clinical Trial Research Center, Xiangya Hospital, Central South University, Changsha, 410008, PR China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, PR China.
| | - Ping-Sheng Xu
- Phase Ⅰ Clinical Trial Research Center, Xiangya Hospital, Central South University, Changsha, 410008, PR China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, PR China.
| |
Collapse
|
25
|
Xu YY, Yi ZH, Li XM, Li D, Pan L, Dai YX, Zhong XF, Yan J, Xu PS, Xu SM. Pharmacokinetics of Flunarizine Hydrochloride After Single Oral Doses in Healthy Subjects: Bioequivalence Study and Food Effects. Clin Pharmacol Drug Dev 2021; 11:341-347. [PMID: 34472200 DOI: 10.1002/cpdd.1012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2021] [Accepted: 07/26/2021] [Indexed: 11/09/2022]
Abstract
We designed a study to compare the newly developed 5-mg flunarizine hydrochloride capsules (test) to that of its marketed counterpart (5-mg; reference) among healthy adult Chinese volunteers. We performed an open-label, single-center study that consisted of 2 randomized, crossover trials, including a fasting trial and a fed trial. In each part of the study, the subjects were randomly assigned to either receive the test or reference products (5-mg flunarizine) in a 1:1 ratio. Subjects then received the alternative products, following a 14-day washout period. Concentrations of plasma flunarizine were analyzed using liquid chromatography-tandem mass spectrometry. Pharmacokinetic parameters (noncompartmental model) were evaluated using the WinNonlin software. The analysis of variance and Food and Drug Administration bioequivalence statistical criterion of 90% confidence interval for 80% to 125% range (set at P ≤ .05) of geometric means ratios of test: reference product for peak plasma concentration, area under the plasma concentration-time curve (AUC) from time 0 to time t, and AUC from time 0 to infinity were determined. Tolerability was evaluated during the entire study period. Overall, 23 volunteers completed the fasting study, while 40 volunteers completed the fed study. The test formulation was found to be bioequivalent to the marketed formulation, as the 90% confidence interval for the ratio of geometric means of peak plasma concentration (fasting: 87.61%-101.67%; fed: 87.38%-104.06%), AUC from time 0 to time t (fasting: 89.44%-99.92%; fed: 92.65%-98.28%), and AUC from time 0 to infinity (fasting: 95.02%-104.33%; fed: 90.41%-96.96%) were within equivalence limits (80-125%) under both the fasting and fed conditions. When flunarizine was given alongside high-fat meals, time to maximum concentration was delayed ≈3.5 hours compared to fasting conditions. Meantime, high-fat meals increased its exposure by nearly 50%. Furthermore, there were no serious adverse events found among the subjects. This study confirmed that test and reference flunarizine hydrochloride capsules were bioequivalent under fasting and postprandial conditions.
Collapse
Affiliation(s)
- Yan-Ying Xu
- Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, PR China
| | - Zhi-Heng Yi
- Hunan Dinuo Pharmaceutical Co. Ltd., Changsha, PR China
| | - Xiao-Min Li
- Phase Ⅰ Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, PR China
| | - Dai Li
- Phase Ⅰ Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, PR China
| | - Lin Pan
- Hunan Dinuo Pharmaceutical Co. Ltd., Changsha, PR China
| | - Yi-Xin Dai
- Phase Ⅰ Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, PR China
| | - Xue-Feng Zhong
- Phase Ⅰ Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, PR China
| | - Juan Yan
- Phase Ⅰ Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, PR China
| | - Ping-Sheng Xu
- Phase Ⅰ Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, PR China.,National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, PR China
| | - Su-Mei Xu
- Phase Ⅰ Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, PR China.,National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, PR China
| |
Collapse
|
26
|
Li LS, Guan K, Li JD, Wang ZX, Cui L, Xu YY. [The effect on patient life quality of prophylactic treatment to seasonal allergic rhinitis and related transcriptomics research]. Zhonghua Yu Fang Yi Xue Za Zhi 2021; 55:606-612. [PMID: 34034400 DOI: 10.3760/cma.j.cn112150-20210228-00198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: The preseason prophylactic treatment of seasonal allergic rhinitis (AR) caused by pollens could alleviate AR symptoms during the pollen season. This study aimed to evaluate the effect of prophylaxis usage of suplatast tosilate on the life quality of AR patients in the pollen season, and investigate the potential mechanism of action through transcriptomic analysis. Methods: This is a randomized controlled study. AR patients allergic to weed pollens were recruited from Allergy Clinic of Peking Union Medical College Hospital from January 2020 to June 2020, and divided into prophylactic group who started to take suplatast tosilate as prophylaxis 2 weeks before the spread of weed pollens[n=10, 4 men and 6 women with age range of (34±6) years old] and control group who did not use any prophylactic treatment[n=24, 12 men and 12 women with age range of (33±9) years old]. The differences of age (t=0.381, P=0.706) and gender (χ²=0.595, P=0.715) distribution between the patients of two groups were not statistically significant. All the subjects filled in the rhinoconjunctivitis quality of life questionnaire (RQLQ) while onset of AR symptoms, and peripheral blood was drawn for transcriptomic analysis 1 month before and during the pollen season. Differences between groups were statistically analyzed through chi-square test and t test. Results: There was no significant difference in visual analogue scale of rhinitis symptom in the last pollen season between prophylactic group and control group[ 8.0 (6.4, 9.3) vs 7.3 (6.1, 8.0), Z=1.180, P=0.254]. The RQLQ score of prophylactic group was superior to that of control group in the weed pollen season (2.9±0.9 vs 3.7±0.9, t=-2.438, P=0.026). 210 differentially expressed genes of fold change ≥2 were identified, with 147 genes upregulated and 63 genes downregulated in the prophylactic group compared to the control group. Gene Ontology annotation showed that IL-12 and IL-23 related pathways were downregulated in prophylactic group (P=0.006 48). Polymerase Chain Reaction (PCR) verification of differentially expressed genes indicated that the relative expression level of HLA-G in prophylactic group was significantly lower than that in control group (0.23±0.19 vs 1.00±0.49,t=4.016, P=0.006). Conclusion: The prophylactic treatment of suplatast tosilate showed some benefit to the life quality of seasonal AR patients during the pollen season, and the potential mechanism might be related with the downregulation of IL-12 and IL-23 pathways and decreased expression of HLA-G.
Collapse
Affiliation(s)
- L S Li
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases, Peking Union Translational Medical Center, Beijing 100730, China
| | - K Guan
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases, Peking Union Translational Medical Center, Beijing 100730, China
| | - J D Li
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases, Peking Union Translational Medical Center, Beijing 100730, China
| | - Z X Wang
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases, Peking Union Translational Medical Center, Beijing 100730, China
| | - L Cui
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases, Peking Union Translational Medical Center, Beijing 100730, China
| | - Y Y Xu
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases, Peking Union Translational Medical Center, Beijing 100730, China
| |
Collapse
|
27
|
Li LS, Guan K, Wang ZX, Cui L, Xu YY. [Appropriate protocol of treatment modulation for seasonal allergic rhinitis caused by cypress pollens]. Zhonghua Yi Xue Za Zhi 2021; 101:1256-1261. [PMID: 34865395 DOI: 10.3760/cma.j.cn112137-20200916-02656] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate appropriate protocol of treatment modulation for seasonal allergic rhinitis (AR) patients, in order to promote the implementation of personalized medicine. Methods: Total of 124 AR patients allergic to cypress pollens were recruited from January to February 2020 in Department of Allergy in Peking Union Medical College Hospital, 43 males and 81 females with an average age of (41±9) years. The patients were divided into two groups with block randomization method. In the first group, treatment was modulated every two days according to the average daily rhinoconjunctivitis symptom score of the last two days (short-term symptom-score group); while in the second group, therapy regimen was adjusted every week based on the Allergic Rhinitis Control Test (ARCT) score of the last week (long-term ARCT group). The treatment level was up-regulated when the cypress pollen count increased and stayed at a high level (step-up pharmacotherapy stage); and treatment was down-regulated while the pollen count decreased (step-down pharmacotherapy stage). Daily symptom scores, medicine scores, and ARCT scores of the two groups were recorded and compared. Results: During the whole cypress pollen season, the daily rhinoconjunctivitis symptom score of short-term symptom-score group was significantly lower than that in long-term ARCT group(2.4±1.0 vs 2.7±1.0, P<0.01), and the difference between the two groups was more pronounced in the step-up pharmacotherapy stage than that in the step-down pharmacotherapy stage, while there was no statistical difference between the daily medicine scores of the two groups (P>0.05). During the pollen rising period, the ARCT score of short-term symptom-score group was significantly better than that of long-term ARCT group (21(19, 22) vs 20 (17, 21), P=0.049); while in the pollen peak period and decreasing period, the ARCT scores of the two groups showed no statistical difference (P>0.05). The proportion of incompliance with doctor's advice was higher in long-term ARCT group compared to that in short-term symptom-score group (30.1% vs 6.7%, P<0.001). Conclusion: The protocol of treatment modulation for seasonal AR patients allergic to pollens should be developed flexibly according to the variation trend of pollen allergen exposure, so as to implement the idea of personalized medicine.
Collapse
Affiliation(s)
- L S Li
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing 100730, China
| | - K Guan
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing 100730, China
| | - Z X Wang
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing 100730, China
| | - L Cui
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing 100730, China
| | - Y Y Xu
- Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing 100730, China
| |
Collapse
|
28
|
Xu LL, Shen WW, Chen XX, Li GX, Xu YY, Gao MY, Zhou SJ, Lin HJ, He N. [HIV-1 drug resistance and subtypes in newly reported HIV/AIDS patients before antiretroviral therapy in Taizhou city, 2016-2018]. Zhonghua Liu Xing Bing Xue Za Zhi 2021; 42:711-715. [PMID: 34814456 DOI: 10.3760/cma.j.cn112338-20200706-00926] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Objective: To explore the HIV-1 drug resistance and subtypes in newly reported HIV/AIDS patients before antiretroviral therapy (ART) in Taizhou city. Methods: A cross-sectional study of HIV-1 drug resistance was conducted among newly reported HIV/AIDS patients before ART in Taizhou from January 2016 to December 2018. HIV-1 pol gene sequences were obtained by RT-PCR. The sequences were submitted to the Stanford University drug resistance database. The drug resistance mutation and the sensitivity of HIV-1 strains to antiretroviral drugs were determined according to WHO Guidelines on HIV drug resistance surveillance of 2014. Results: A total of 806 HIV-1 pol gene sequences were obtained successfully. The overall HIV-1 drug resistance rate was 2.9% (23/806), 1.9% for non-nucleoside reverse transcriptase inhibitors (NNRTIs), 0.6% for nucleoside reverse transcriptase inhibitors (NRTIs), and 0.0% for protease inhibitors (PIs), respectively. From 2016 to 2018, the HIV-1 drug resistance rate was 1.6%, 1.8%, and 4.8%, respectively. The resistance mutations of NNRTIs and NRTIs were mainly K103 N (0.7%) and M184I/V (0.5%). HIV-1 subtypes were mostly CRF01_AE (42.7%,344/806),CRF07_BC (28.9%,233/806) and CRF08_BC (11.2%,90/806).HIV-1 subtypes among homosexually transmitted infections were mostly CRF01_AE (53.3%, 136/255) and CRF07_BC (32.2%, 82/255), and HIV-1 subtypes among heterosexually transmitted infections were mainly CRF01_AE (37.7%, 203/539), CRF07_BC (27.5%, 148/539) and CRF08_BC (16.1%, 87/539). Conclusion: HIV-1 drug resistance rate among newly reported HIV/AIDS patients before ART remained low in Taizhou during 2016 to 2018, an increasing trend seemed to be notifiable and warrants continuous surveillance of HIV-1 drug resistance.
Collapse
Affiliation(s)
- L L Xu
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China
| | - W W Shen
- Taizhou City Center for Disease Control and Prevention, Taizhou 318000, China
| | - X X Chen
- Taizhou City Center for Disease Control and Prevention, Taizhou 318000, China
| | - G X Li
- Taizhou City Center for Disease Control and Prevention, Taizhou 318000, China
| | - Y Y Xu
- Taizhou City Center for Disease Control and Prevention, Taizhou 318000, China
| | - M Y Gao
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China
| | - S J Zhou
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China
| | - H J Lin
- Taizhou City Center for Disease Control and Prevention, Taizhou 318000, China
| | - N He
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China
| |
Collapse
|
29
|
Qiao SJ, Zhou SJ, Xu LL, Chen XX, Xu YY, Shen WW, Liu X, Lin HJ, He N. [Prevalence and correlates of plasma cytomegalovirus viremia among newly reported HIV/AIDS patients in Taizhou city, 2017-2018]. Zhonghua Liu Xing Bing Xue Za Zhi 2021; 42:316-320. [PMID: 33626622 DOI: 10.3760/cma.j.cn112338-20200420-00601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the prevalence and correlates of plasma cytomegalovirus (CMV) viremia among newly reported antiretroviral therapy (ART)-naive HIV/AIDS patients in Taizhou during 2017-2018. Methods: CMV DNA was measured in plasma specimens of newly reported ART-naive HIV/AIDS patients by quantitative PCR. Both univariable and multivariable logistic regression analyses were carried out to evaluate CMV viremia correlations among the individuals. Results: Of 612 HIV/AIDS patients, 480 (78.4%) were male, 125 (20.4%) were over 60 years old, 177 (28.9%) were infected via homosexual transmission, and 430 (70.3%) via heterosexual transmission. The prevalence of CMV viremia among HIV/AIDS patients was 13.4% (82/612). Multivariable logistic regression analysis showed that the risk of CMV viremia in CD4+ lymphocyte cells counts (CD4+) ≤200 cells/μl group was higher than CD4 counts >500 cells/μl (OR=5.10, 95%CI:1.74-14.96, P=0.003); The median CMV DNA level (log10) of 82 viremic patients was 1.57 (P25,P75:1.04,2.13); Viremic patients with CD4 counts ≤200 cells/μl had the highest CMV viral load (P<0.01). Conclusions: Among ART-naive HIV/AIDS patients, the prevalence of CMV viremia was significantly associated with immunodeficiency status. Further research is needed to evaluate the association between CMV viremia and the course of HIV infection.
Collapse
Affiliation(s)
- S J Qiao
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China
| | - S J Zhou
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China
| | - L L Xu
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China
| | - X X Chen
- Taizhou City Center for Disease Control and Prevention, Taizhou 318000, China
| | - Y Y Xu
- Taizhou City Center for Disease Control and Prevention, Taizhou 318000, China
| | - W W Shen
- Taizhou City Center for Disease Control and Prevention, Taizhou 318000, China
| | - X Liu
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China
| | - H J Lin
- Taizhou City Center for Disease Control and Prevention, Taizhou 318000, China
| | - N He
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China
| |
Collapse
|
30
|
He JY, Wang SL, Xu YY, Shen WW, Ding YY, Lin HJ, He N, Chen XX. [Influencing factors of antiretroviral therapy and its association with immunological effect among HIV/AIDS patients in Taizhou city, 2006-2019]. Zhonghua Liu Xing Bing Xue Za Zhi 2021; 41:2093-2097. [PMID: 33378822 DOI: 10.3760/cma.j.cn112338-20200611-00833] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyze influencing factors of instant antiretroviral therapy (ART) and explore associution between strategies of ART and immunological effects among HIV/AIDS patients in Taizhou city during 2006-2019. Methods: A retrospective cohort study was conducted on HIV/AIDS patients under ART, and a logistic regression model was used to analyze factors of instant ART. The student t-test and chi-square test were used to compare immunological effect of different ART strategies while the Kaplan-Meier method was used to generate a survival curve. Results: A total of 2 971 HIV/AIDS patients were enrolled with 1 786 cases (60.1%) having instant ART strategy. The proportion of instant ART were 77.8% (1 170/1 504) during 2016 to 2019. The treatment success rate of the instant ART group (87.4%, 1 561/1 786) were higher than the delayed ART group (84.4%, 1 000/1 185). The results of multivariate logistic regression model indicated that male (aOR=1.28, 95%CI: 1.03-1.59), married (aOR=1.71, 95%CI: 1.33-2.19) and baseline CD(4)(+)T lymphocyte cells (CD(4)) counts ≤200 cells/μl (aOR=1.60, 95%CI: 1.27-2.02) were factors positively related to instant ART while 31-40 years old (aOR=0.63, 95%CI: 0.48-0.84), infected through heterosexual transmission(aOR=0.60, 95%CI: 0.49-0.74) and diagnosed before 2015 (aOR=0.20, 95%CI: 0.17-0.23) were inversely related to instant ART. The increase of the CD(4)/CD(8) ratio was greater, and the cumulative ART success rate was higher each year in the instant ART group than in the delayed ART group (P<0.05). Conclusions: The instant ART strategy has been well implemented in Taizhou city during 2006-2019, and the immunological effect was better in instant ART group. The proportion of instant ART were more than 60.0% among HIV/AIDS patients. Instant ART strategy needs to be strengthened for those who are 31-40 years old, women, unmarried, and infected through heterosexual transmission in an attempt to further increase treatment level and improve treatment effect.
Collapse
Affiliation(s)
- J Y He
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China
| | - S L Wang
- Taizhou Prefectural Center for Disease Control and Prevention, Taizhou 318000, China
| | - Y Y Xu
- Taizhou Prefectural Center for Disease Control and Prevention, Taizhou 318000, China
| | - W W Shen
- Taizhou Prefectural Center for Disease Control and Prevention, Taizhou 318000, China
| | - Y Y Ding
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China
| | - H J Lin
- Taizhou Prefectural Center for Disease Control and Prevention, Taizhou 318000, China
| | - N He
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China
| | - X X Chen
- Taizhou Prefectural Center for Disease Control and Prevention, Taizhou 318000, China
| |
Collapse
|
31
|
Zhu J, Chen YS, Zhang YH, Ding LL, Wang J, Xu YY, Chen JG. [An analysis of mortality trends for lung cancer during 1972-2016 in Qidong city of Jiangsu Province]. Zhonghua Yu Fang Yi Xue Za Zhi 2020; 54:1457-1460. [PMID: 33333667 DOI: 10.3760/cma.j.cn112150-20200227-00195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Crude mortality rate (CR) for lung cancer in Qidong increased from 11.50/105 in 1972-1976 to 76.61/105 in 2012-2016, China age-standardized rate (CASR) from 13.11/105 in 1972-1976 to 34.27/105 in 2012-2016, and World age-standardized rate (WASR) from 13.40/105 in 1972-1976 to 34.30/105 in 2012-2016. The average annual percentage change (AAPCs) of CR, CASR, WASR were 4.87% (95%CI: 4.63%-5.12%), 2.17% (95%CI: 1.96%-2.38%), 2.12% (95%CI: 1.92%-2.33%) (all P values<0.001), respectively. AAPCs for 45-54, 55-64, 65-74 and over 75 age groups were 0.74% (95%CI: 0.36%-1.11%), 1.23% (95%CI: 0.92%-1.53%), 2.55% (95%CI: 2.20%-2.90%), 4.26% (95%CI: 3.56%-4.96%) (all P values<0.001), respectively.
Collapse
Affiliation(s)
- J Zhu
- Qidong People's Hospital, Qidong Liver Cancer Institute, the Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - Y S Chen
- Qidong People's Hospital, Qidong Liver Cancer Institute, the Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - Y H Zhang
- Qidong People's Hospital, Qidong Liver Cancer Institute, the Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - L L Ding
- Qidong People's Hospital, Qidong Liver Cancer Institute, the Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - J Wang
- Qidong People's Hospital, Qidong Liver Cancer Institute, the Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - Y Y Xu
- Qidong People's Hospital, Qidong Liver Cancer Institute, the Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| | - J G Chen
- Qidong People's Hospital, Qidong Liver Cancer Institute, the Affiliated Qidong Hospital of Nantong University, Qidong 226200, China
| |
Collapse
|
32
|
Dou LJ, Zhang QF, Bao HH, Wu WK, Sheng J, Yan SQ, Xu YY, Gu CL, Huang K, Cao H, Su PY, Tao FB, Hao JH. [A birth cohort study of the association between prenatal serum bisphenol A concentration and infant neurobehavior development]. Zhonghua Yu Fang Yi Xue Za Zhi 2020; 54:644-650. [PMID: 32842280 DOI: 10.3760/cma.j.cn112150-20190902-00696] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the association between maternal bisphenol A (BPA) exposure during pregnancy and neurobehavioral development in infant. Methods: Participants were from the Ma'anshan Birth Cohort, which was established from October 2008 to October 2010 based on four municipal medical and health institutions in Ma'anshan. High-performance liquid chromatography-tandem mass spectrometry was applied for the determination of serum BPA concentration in 1 783 pregnant women sampled at their first filing, and during 2.97 to 28.1 months age of the infants. Neurobehavioral development were assessed by 0-6-year-old pediatric examination table of neuropsychological development. Generalized linear model was used to analyze the association between serum BPA levels during pregnancy and infants' neurobehavioral development. Results: A total of 931 mother-child pairs had complete data on serum BPA detection during pregnancy and assessment of infants' neurobehavioral development status. The age of pregnant women at their first filing was (26.67±3.45) years old, and the M (P25,P75) of serum BPA concentration (ng/ml) was 0.23 (0.11, 0.52), with a detection rate of 84.1% (783/931). The age of infants was (13.18±5.46) months, and 53.5% (498) were boys. The developmental quotient scores of large motor, fine motor, adaptive ability, language ability and social behaviors of infants were (97.88±16.32), (97.16±15.35), (99.64±15.47), (95.3±16.04) and (98.95±14.76) points, respectively. Generalized linear model showed that after adjusting for factors such as delivery mode, feeding mode, family per capita monthly income, preterm delivery, gender, maternal age, residence, pre-pregnancy body mass index and residence time, serum BPA level in pregnancy was negatively associated with infant's development of social behavior [β (95%CI):-2.42 (-4.71, -0.12)]. The post-stratification analysis by infant age revealed that the serum BPA level in pregnancy was only negatively associated with the development of language and social behavior developmental quotient scores in infants between the ages of 12 and 18 months, with β (95%CI) about -6.66 (-13.06, -0.25) and -7.401 (-12.97, -1.83), respectively. Conclusion: BPA exposure during pregnancy affects language and social behavior development in infants, and the detection window is between 12 and 18 months old of the infant.
Collapse
Affiliation(s)
- L J Dou
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University/Ministry of Education Key Laboratory of Health of New-born Population, Hefei 230032, China
| | - Q F Zhang
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University/Ministry of Education Key Laboratory of Health of New-born Population, Hefei 230032, China
| | - H H Bao
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University/Ministry of Education Key Laboratory of Health of New-born Population, Hefei 230032, China
| | - W K Wu
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University/Ministry of Education Key Laboratory of Health of New-born Population, Hefei 230032, China
| | - J Sheng
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University/Ministry of Education Key Laboratory of Health of New-born Population, Hefei 230032, China
| | - S Q Yan
- Department of Child Health Care, Maternal and Child Health Care Center of Ma'anshan, Ma'anshan 243000, Anhui Province, China
| | - Y Y Xu
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University/Ministry of Education Key Laboratory of Health of New-born Population, Hefei 230032, China
| | - C L Gu
- Department of Child Health Care, Maternal and Child Health Care Center of Ma'anshan, Ma'anshan 243000, Anhui Province, China
| | - K Huang
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University/Ministry of Education Key Laboratory of Health of New-born Population, Hefei 230032, China
| | - H Cao
- Department of Child Health Care, Maternal and Child Health Care Center of Ma'anshan, Ma'anshan 243000, Anhui Province, China
| | - P Y Su
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University/Ministry of Education Key Laboratory of Health of New-born Population, Hefei 230032, China
| | - F B Tao
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University/Ministry of Education Key Laboratory of Health of New-born Population, Hefei 230032, China
| | - J H Hao
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University/Ministry of Education Key Laboratory of Health of New-born Population, Hefei 230032, China
| |
Collapse
|
33
|
Zhang N, Mao Z, Cui YQ, Xu YY, Zhang HH, Tan YH. [The derivation and vulidafion of a prediction rule for hypoxemia in infants with Pierre Robin sequence after weaning]. Zhonghua Yi Xue Za Zhi 2020; 100:1180-1184. [PMID: 32311884 DOI: 10.3760/cma.j.cn112137-20190730-01703] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To set up a prediction scoring system for the hypoxemia in infants with Pierre Robin sequence after weaning and evaluate its clinical value. Methods: Data of consecutive patients from November 2016 to June 2019, who underwent mandibular distraction osteogenesis in Guangzhou Women and Children's Medical Center, were retrospectively analyzed (n=148). All the cases were divided into two groups according to the appearance of hypoxemia after weaning. They were randomly divided into the derivation cohorc (2/3,n=100) and the validation cohort (1/3,n=48). Single factor and multiple logistic regression analysis were used to select the independent risk factors related to hypoxemia and establish a prediction model. A prediction scoring system was developed in accordance with assigning of the value of each variable β in the model. Internal verification of scoring system by validation population. Data of consecutive patients from July 2019 to November 2019, who underwent mandibular distraction osteogenesis, were prospectively analyzed (n=26). The diagnostic accuracy were conducted to evaluate the clinical value of the scoring system. Results: The logistic regression demonstrated that age at operation, pulmonary infection and the length of distraction less than 5 mm at weaning were the independent risk factors for hypoxemia. The P value of logistic regression model in Hosmer and Lemeshow goodness of fit test was 0.848, and a prediction scoring system was established accordingly. The area under the ROC curve of the scoring system was 0.890, and the optimum critical value was 53. The sensitivity, specificity, accuracy of the model were 78.6%(11/14),86.1%(74/86), 85.0%(85/100) respectively. The predictive effectiveness of the scoring system in the retrospective validation population was similar to that in the modeling population. 26 patients were included in the prospective analysis. The area under ROC curve of the scoring system was 0.870. The sensitivity, specificity and accuracy were 80.0%(5/6),95.0%(20/21), 96.1%(25/26) respectively. Conclusion: The prediction scoring system established in the study are efficacious for the hypoxemia in infants with Pierre Robin sequence after weaning.
Collapse
Affiliation(s)
- N Zhang
- Department of Anaesthesia and Prioperative, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - Z Mao
- Department of Stomatology, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - Y Q Cui
- Department of Stomatology, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - Y Y Xu
- Department of Anaesthesia and Prioperative, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - H H Zhang
- Department of Anaesthesia and Prioperative, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - Y H Tan
- Department of Anaesthesia and Prioperative, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| |
Collapse
|
34
|
Meng TG, Wu LY, Zhang SL, Xu YY, Li X, Zhang JG. [Vertical Distribution of Soil Dissolved Carbon and Its Influencing Factors in the Artificial Shelterbelt Irrigated with Saline Water in an Extreme Drought Desert]. Huan Jing Ke Xue 2020; 41:1950-1959. [PMID: 32608704 DOI: 10.13227/j.hjkx.201909003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Dissolved carbon (DC) is the most active carbon fraction in soils. Vegetation restoration and reconstruction accelerate the carbon cycle in arid desert regions. Studying the DC distribution in soil profiles of artificial shelterbelt under saline irrigation can provide theoretical support and decision-making basis for artificial shelterbelt management, development, and utilization in arid desert areas. In this study, we took the artificial shelterbelts drip-irrigated with five different mineralization and one shifting sandy land (CK) along the Taklimakan Desert Highway as sampling plots, analyzed and discussed the vertical distribution characteristics of soil dissolved organic carbon (SDOC) and dissolved inorganic carbon (SDIC) in the 0-1 m profiles, and further analyzed their relationships among different factors. The results showed that SDOC and SDIC of CK and shelterbelts under 2.82 g·L-1 irrigation showed an "I" type distribution with a linear function relationship. The SDOC and SDIC of four other treatments showed a "Γ" type distribution with power function relationships. The fluctuation ability and contribution degree of SDOC and SDIC of different treatments in the surface layer were higher than those in the lower layers, and the fluctuation and contribution intensity of SDOC were higher than those of SDIC. Except for 2.82 g·L-1 treatment, the average SDOC contents of other treatments were 2-4 times those of SDIC. The average SDOC content of 2.82 g·L-1 treatment was lower than CK; other treatments were 3-5 times that of CK; and the average SDIC content of all treatments increased 15.0%-57.9% than CK. For the 0-5 cm layer, SDOC content increased with the irrigation water mineralization except the 2.82 g·L-1 treatment, but SDIC content firstly increased and then decreased with increasing mineralization, and that for the 4.82 g·L-1 treatment was highest. The SDOC and SDIC were positively correlated with EC, SOC, irrigation water mineralization, SIC, and soil moisture, for which they both showed a weak positive correlation with soil moisture; they were negatively correlated with soil depth. The SDOC and SDIC showed a weak negative correlation and a weak positive correlation with pH, respectively. In summary, the mineralization of irrigation water has an important impact on the vertical distribution of SDOC and SDIC, and their distribution also has close relationships with EC, SOC, SIC, soil moisture, and soil depth, which is of great significance for plantations in extremely drought deserts.
Collapse
Affiliation(s)
- Tian-Ge Meng
- Ministry of Agriculture Key Laboratory of Plant Nutrition and the Agro-environment in Northwest China, College of Natural Resources and Environment, Northwest A&F University, Yangling 712100, China
| | - Lu-Yao Wu
- Ministry of Agriculture Key Laboratory of Plant Nutrition and the Agro-environment in Northwest China, College of Natural Resources and Environment, Northwest A&F University, Yangling 712100, China
| | - Shao-Lei Zhang
- Ministry of Agriculture Key Laboratory of Plant Nutrition and the Agro-environment in Northwest China, College of Natural Resources and Environment, Northwest A&F University, Yangling 712100, China
| | - Yan-Ying Xu
- Ministry of Agriculture Key Laboratory of Plant Nutrition and the Agro-environment in Northwest China, College of Natural Resources and Environment, Northwest A&F University, Yangling 712100, China
| | - Xiong Li
- Ministry of Agriculture Key Laboratory of Plant Nutrition and the Agro-environment in Northwest China, College of Natural Resources and Environment, Northwest A&F University, Yangling 712100, China
| | - Jian-Guo Zhang
- Ministry of Agriculture Key Laboratory of Plant Nutrition and the Agro-environment in Northwest China, College of Natural Resources and Environment, Northwest A&F University, Yangling 712100, China.,State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau, Yangling 712100, China
| |
Collapse
|
35
|
Li LS, Guan K, Wang ZX, Cui L, Xu YY. [The comparison of step-down pharmacotherapy and maintaining dose therapy for seasonal allergic rhinitis]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2020; 34:9-12;18. [PMID: 32086889 PMCID: PMC10128578 DOI: 10.13201/j.issn.1001-1781.2020.01.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 10/02/2019] [Indexed: 11/12/2022]
Abstract
Objective:There is no standard algorithm for the modulation of pharmacologic treatment of allergic rhinitis. This study aimed to recruited allergic rhinitis patients caused by cypress pollens, and compare the step-down pharmacotherapy guided by pollen count and the maintaining therapy which keeps the previous medicine dose when the pollen count decreased. Method:This was a randomized, open-labelled, parallel control study. During the period after the pollen peak when the cypress pollen count decreased and stayed at a low level, allergic rhinitis patients were randomly divided into two groups. In the step-down group(n=67) medicine dose was reduced, while the maintaining group(n=68) kept taking the same dose as in the peak season. The rhinitis symptom score and medicine score of these two groups were recorded and compared. Result:The daily rhinitis symptom score of the step-down group showed no significant difference with the symptom score of the maintaining group, 2.45±0.32 vs 2.43±0.41, P=0.788. But the medicine score of step-down group(3.67±0.98) was significantly lower than that of maintaining group(4.78±0.70), P<0.001. The compliance of step-down group(80.6%) was also better than maintaining group(60.3%), P=0.014. However, in the subgroup of patients with severe rhinitis symptoms, the symptoms of patients taking step-down therapy tended to be more severe than those maintaining the same dose. Conclusion:During the later period of the pollen season when the pollen count was relatively low, the step-down pharmacotherapy guided by pollen count could reduce the medication use, increase the compliance of patients while controlling their rhinitis symptoms effectively. But this strategy might be more suitable for patients with milder symptoms, the severe rhinitis sufferers should be cautious before reducing their medicine dose.
Collapse
Affiliation(s)
- L S Li
- Department of Allergy,Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases,National Clinical Research Center for Immunologic Diseases,Chinese Academy of Medical Sciences & Peking Union Medical College,Peking Union Medical College Hospital,Beijing,100730,China
| | - K Guan
- Department of Allergy,Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases,National Clinical Research Center for Immunologic Diseases,Chinese Academy of Medical Sciences & Peking Union Medical College,Peking Union Medical College Hospital,Beijing,100730,China
| | - Z X Wang
- Department of Allergy,Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases,National Clinical Research Center for Immunologic Diseases,Chinese Academy of Medical Sciences & Peking Union Medical College,Peking Union Medical College Hospital,Beijing,100730,China
| | - L Cui
- Department of Allergy,Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases,National Clinical Research Center for Immunologic Diseases,Chinese Academy of Medical Sciences & Peking Union Medical College,Peking Union Medical College Hospital,Beijing,100730,China
| | - Y Y Xu
- Department of Allergy,Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases,National Clinical Research Center for Immunologic Diseases,Chinese Academy of Medical Sciences & Peking Union Medical College,Peking Union Medical College Hospital,Beijing,100730,China
| |
Collapse
|
36
|
Zheng WS, Guan LX, Cheng LC, Hu YL, Xu YY, Yang T, Peng B, Wu YL, Bo J, Wang QS, Gao XN. [Ruxolitinib in the treatment of two cases of chronic neutrophilic leukemia]. Zhonghua Zhong Liu Za Zhi 2020; 42:113-114. [PMID: 32135644 DOI: 10.3760/cma.j.issn.0253-3766.2020.02.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Affiliation(s)
- W S Zheng
- Department of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya 572000, China
| | - L X Guan
- Department of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya 572000, China
| | - L C Cheng
- Department of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya 572000, China
| | - Y L Hu
- Department of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya 572000, China
| | - Y Y Xu
- Department of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya 572000, China
| | - T Yang
- Department of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya 572000, China
| | - B Peng
- Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Y L Wu
- Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - J Bo
- Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - Q S Wang
- Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China
| | - X N Gao
- Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China
| |
Collapse
|
37
|
Liao SJ, Xu YY, Sun RJ, Lyu QY. National natural science foundation of China leads the comprehensive development of basic research in the field of male reproductive health in China. Asian J Androl 2020; 22:547-548. [PMID: 31898585 PMCID: PMC7705973 DOI: 10.4103/aja.aja_129_19] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Affiliation(s)
- Shu-Jie Liao
- Department of Health Science, National Natural Science Foundation of China, Beijing 100085, China.,Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - Yan-Ying Xu
- Department of Health Science, National Natural Science Foundation of China, Beijing 100085, China
| | - Rui-Juan Sun
- Department of Health Science, National Natural Science Foundation of China, Beijing 100085, China
| | - Qun-Yan Lyu
- Department of Health Science, National Natural Science Foundation of China, Beijing 100085, China
| |
Collapse
|
38
|
Liao SJ, Xu YY, Sun RJ, Lyu QY. [The development of basic research in the field of male reproductive health in China over the past 30 years supported by the National Natural Science Foundation of China]. Zhonghua Nan Ke Xue 2020; 26:3-16. [PMID: 33345471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Reproductive health is a key aim of the population health strategy, and male reproductive health constitutes an important part of reproductive health. This article systematically analyzes the applications to and grants from the National Natural Science Foundation of China (NSFC) and some related scientific problems in the field of male reproductive health in the past 30 years. It also discusses the development of the basic researches on male reproductive health in China and the facilitating role of NSFC in this field.
Collapse
Affiliation(s)
- Shu-Jie Liao
- Department of Health Science, National Natural Science Foundation of China, Beijing 100085, China
- Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China
| | - Yan-Ying Xu
- Department of Health Science, National Natural Science Foundation of China, Beijing 100085, China
| | - Rui-Juan Sun
- Department of Health Science, National Natural Science Foundation of China, Beijing 100085, China
| | - Qun-Yan Lyu
- Department of Health Science, National Natural Science Foundation of China, Beijing 100085, China
| |
Collapse
|
39
|
Qi ZY, Wang F, Yue YY, Guo XW, Guo RM, Li HL, Xu YY. CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo. J Ovarian Res 2019; 12:118. [PMID: 31783885 PMCID: PMC6884760 DOI: 10.1186/s13048-019-0593-2] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2019] [Accepted: 11/14/2019] [Indexed: 12/12/2022] Open
Abstract
Ovarian cancer (OC) is a type of gynaecological malignancy with high mortality in females. Serous ovarian cancer (SOC) is a distinct subtype of OC with poor early diagnosis. Given the limitations of traditional therapies, such as chemotherapy, targeted treatment is therefore a promising therapy to improve the survival rate of SOC patients. Cyclophilin A (CYPA) is a member of Cyclophilin family and thought to participates in multiple cellular processes such as cell transduction and immune modulation. Recently, various of studies indicated that CYPA has critical impact on cancer progression. CYPA could regulate cell proliferation, invasion, and chemoresistance of multiple types of cancers. However, it is still unclear whether it could affect ovarian cancer. In this study, we demonstrated that CYPA was highly expressed in SOC tissues compared with adjacent tissues. Further, CYPA was significantly associated with clinical stage and lymphnode metastasis of SOC patients. Additionally, data indicated that knockdown of CYPA by its shRNA dramatically reduces migration and invasion capacity of SOC cells in vitro and blocks tumor metastasis in vivo. Our study investigates the involvement of CYPA in the progression and metastasis of SOC, and therefore provides CYPA as a promising therapeutic target for SOC treatment.
Collapse
Affiliation(s)
- Zhi-Ying Qi
- Department of gynecolog, the second hospital of Tianjin medical university, No.23 Pingjiang road, Hexi district, Tianjin, 300211 China
| | - Fang Wang
- Department of gynecolog, the second hospital of Tianjin medical university, No.23 Pingjiang road, Hexi district, Tianjin, 300211 China
| | - Ying-Ying Yue
- Department of gynecolog, the second hospital of Tianjin medical university, No.23 Pingjiang road, Hexi district, Tianjin, 300211 China
| | - Xue-Wang Guo
- Department of gynecolog, the second hospital of Tianjin medical university, No.23 Pingjiang road, Hexi district, Tianjin, 300211 China
| | - Rui-Meng Guo
- Department of gynecolog, the second hospital of Tianjin medical university, No.23 Pingjiang road, Hexi district, Tianjin, 300211 China
| | - Hong-Lin Li
- Department of gynecolog, the second hospital of Tianjin medical university, No.23 Pingjiang road, Hexi district, Tianjin, 300211 China
| | - Yan-Ying Xu
- Department of gynecolog, the second hospital of Tianjin medical university, No.23 Pingjiang road, Hexi district, Tianjin, 300211 China
| |
Collapse
|
40
|
Li HL, Sun JJ, Ma H, Liu SJ, Li N, Guo SJ, Shi Y, Xu YY, Qi ZY, Wang YQ, Wang F, Guo RM, Liu D, Xue FX. MicroRNA-23a inhibits endometrial cancer cell development by targeting SIX1. Oncol Lett 2019; 18:3792-3802. [PMID: 31579409 PMCID: PMC6757317 DOI: 10.3892/ol.2019.10694] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2018] [Accepted: 06/05/2019] [Indexed: 12/27/2022] Open
Abstract
The present study focused on exploring the inhibitory mechanism of microRNA (miR)-23a in endometrial cancer. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was used to investigate miR-23a expression in endometrial tissues and endometrial cancer cells. A colony formation assay using crystal violet staining was performed to compare cell proliferation, while wound-healing and Transwell assays were performed to compare cell migration and invasion. Subsequently, bioinformatics and a luciferase reporter gene assay were used to investigate the effect of miR-23a on sine oculis homeobox homolog 1 (SIX1) expression, and the biological function of SIX1 was analyzed. Additionally, a nude mouse tumorigenicity assay was performed to test the inhibitory effect of miR-23a and Taxol® therapy in endometrial cancer. Finally, immunohistochemistry and RT-qPCR were used to explore the association between miR-23a and SIX1 expression in endometrial cancer tissues. miR-23a was underexpressed in endometrial cancer tissues compared with in para-carcinoma tissues, and the overexpression of miR-23a inhibited proliferation and invasion of endometrial cancer cells. Furthermore, SIX1 was demonstrated to be a downstream target of miR-23a, and miR-23a reduced SIX1 expression. Additionally, SIX1 inversely promoted cell proliferation, migration and invasion. In addition, the effects of reduced cell proliferation and increased cell invasion following miR-23a overexpression could be reversed by adding SIX1 to in vitro culture. Furthermore, the inhibitory effect of miR-23a and Taxol therapy, which reduced SIX1 expression in endometrial cancer, was demonstrated in vivo. Finally, a negative association between miR-23a and SIX1 expression was demonstrated in endometrial cancer tissues. The results of the present study revealed that miR-23a may inhibit endometrial cancer development by targeting SIX1.
Collapse
Affiliation(s)
- Hong-Lin Li
- Department of Obstetrics and Gynecology, The Secondary Hospital of Tianjin Medical University, Tianjin 300211, P.R. China
| | - Jun-Jie Sun
- Department of Obstetrics and Gynecology, The Secondary Hospital of Tianjin Medical University, Tianjin 300211, P.R. China
| | - Hui Ma
- Department of Obstetrics and Gynecology, The Secondary Hospital of Tianjin Medical University, Tianjin 300211, P.R. China
| | - Shen-Jia Liu
- Department of Obstetrics and Gynecology, The Secondary Hospital of Tianjin Medical University, Tianjin 300211, P.R. China
| | - Na Li
- Department of Obstetrics and Gynecology, The Secondary Hospital of Tianjin Medical University, Tianjin 300211, P.R. China
| | - Su-Jie Guo
- Department of Obstetrics and Gynecology, The Secondary Hospital of Tianjin Medical University, Tianjin 300211, P.R. China
| | - Yang Shi
- Department of Obstetrics and Gynecology, The Secondary Hospital of Tianjin Medical University, Tianjin 300211, P.R. China
| | - Yan-Ying Xu
- Department of Obstetrics and Gynecology, The Secondary Hospital of Tianjin Medical University, Tianjin 300211, P.R. China
| | - Zhi-Ying Qi
- Department of Obstetrics and Gynecology, The Secondary Hospital of Tianjin Medical University, Tianjin 300211, P.R. China
| | - Yu-Quan Wang
- Department of Obstetrics and Gynecology, The Secondary Hospital of Tianjin Medical University, Tianjin 300211, P.R. China
| | - Fang Wang
- Department of Obstetrics and Gynecology, The Secondary Hospital of Tianjin Medical University, Tianjin 300211, P.R. China
| | - Rui-Meng Guo
- Department of Obstetrics and Gynecology, The Secondary Hospital of Tianjin Medical University, Tianjin 300211, P.R. China
| | - Dong Liu
- Department of Obstetrics and Gynecology, The Secondary Hospital of Tianjin Medical University, Tianjin 300211, P.R. China
| | - Feng-Xia Xue
- Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China
| |
Collapse
|
41
|
Xu YY, Shen FJ, Wu LL. [Effect of benazepril on nuclear factor E2 related factor 2, nicotinamide adenine dinucleotide phosphate oxidase and reactive oxygen species in rats with hepatic fibrosis]. Zhonghua Gan Zang Bing Za Zhi 2019; 27:677-680. [PMID: 31594091 DOI: 10.3760/cma.j.issn.1007-3418.2019.09.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the effect of benazepril on the expression of nuclear factor E2 related factor 2 (Nrf2), nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) and reactive oxygen species (ROS) concentration in rats with hepatic fibrosis and to explore the possible antifibrotic mechanism of benazepril. Methods: Twenty-two healthy male Sprague-Dawley rats were randomly divided into 3 groups: control group (6 rats), model group (8 rats) and benazepril treatment group (8 rats). Two rats died during modeling and treatment in the model group and the benazepril treatment group, and a model of hepatic fibrosis induced by carbon tetrachloride (CCL(4)) was established. The rats in benazepril group were given benazepril for 8 weeks by gastric gavage. The assessment of liver tissue damage in each group was measured using conventional hematoxylin-eosin and Masson staining. The mRNA level of Nrf2, NOX4 in liver tissue was detected by RT-PCR, and serum ROS concentration was determined by colorimetry. All data were expressed in mean ± standard deviations, and were analyzed using SPSS21.0 statistical software. The data were compared using one-way analysis of variance, and the LSD-t method was used for pairwise comparison between the two groups. The correlation analysis was performed by Spearman's correlation analysis. Results: In the liver of the model group, with the aggravation of liver fibrosis the expression of Nrf2mRNA, NOX4 mRNA and ROS concentration were higher than control group [(4.01 ± 3.40), (31.78 ± 3.96), (1.82 ± 0.46) μg/ ml vs. (0.12 ± 0.11), (2.03 ± 0.31), (1.56±0.84) μg/ml, P < 0.05]. After benazepril treatment, NOX4 mRNA expression and ROS concentration were decreased than the model group [(15.93 ± 5.01), (0.78 ± 0.44) μg/ml vs. (31.78 ± 3.96), (1.82 ± 0.46) μg /ml, P < 0.05], while Nrf2 mRNA expression was higher than the model group [(6.69 ± 4.86) vs. (4.01 ± 3.40), P < 0.05]. There was a positive correlation between Nrf2 and NOX4, Nrf2 and ROS, and NOX4 and ROS (r = 0.616, 0.411, 0.802, P < 0.05). Conclusion: Benazepril may exert an anti-hepatic fibrosis effect by activating Nrf2 expression, or may inhibit the ROS-mediated oxidative stress in response to NOX4.
Collapse
Affiliation(s)
- Y Y Xu
- Gastroenterology Department, The First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | | | | |
Collapse
|
42
|
Li HN, Chen H, Yang XX, Xu YY, Cao Y, Geng JS, Jin XM, Meng HX. IgA nephropathy and renal cell carcinoma: molecular genetic analysis. J BIOL REG HOMEOS AG 2019; 33:1571-1575. [PMID: 31496210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Affiliation(s)
- H N Li
- Department of Pathology, Harbin Medical University, Harbin, China
- Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China
- Department of Pathology, The First Affiliated Hospital of Hei Longjiang University of Chinese Medicine, Harbin, China
| | - H Chen
- Department of Urinary Surgery, Harbin Medical University Cancer Hospital, Harbin, China
| | - X X Yang
- Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China
| | - Y Y Xu
- Department of Urinary Surgery, Harbin Medical University Cancer Hospital, Harbin, China
| | - Y Cao
- Department of Urinary Surgery, Harbin Medical University Cancer Hospital, Harbin, China
| | - J S Geng
- Department of Pathology, Harbin Medical University, Harbin, China
- Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China
| | - X M Jin
- Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China
| | - H X Meng
- Department of Pathology, Harbin Medical University, Harbin, China
- Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China
| |
Collapse
|
43
|
Qiao XT, Chen XX, Lin HJ, Ning CX, Xu YY, Shen WW, Zhao D, Ding YY, He N. [Prevalence of alcohol use and related factors in HIV positive and HIV negative males]. Zhonghua Liu Xing Bing Xue Za Zhi 2019; 40:493-498. [PMID: 31177726 DOI: 10.3760/cma.j.issn.0254-6450.2019.05.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To understand the prevalence of alcohol use and related factors in HIV positive and HIV negative males. Methods: Baseline data were from the prospective cohort study of comparative HIV and aging research in Taizhou of Zhejiang province from January to December, 2017. The information about alcohol use in the last month was collected through a face-to-face questionnaire interview. Participants were categorized into non-current drinkers, light/moderate drinkers and heavy drinkers according to the US National Institute on Alcoholism and Alcohol Abuse (NIAAA) standard. Results: A total of 1 367 HIV positive males and 2 418 HIV negative males were included. Current alcohol use rate (35.2%, 481/1 367) and heavy alcohol use rate (5.0%, 24/481) were significantly lower in HIV positive males than in HIV negative males (48.0%, 1 161/2 418; 23.5%, 273/1 161), but the proportion of drinking wine and yellow rice wine were significantly higher (21.8%, 105/481; 9.1%, 44/481) in HIV positive males than in HIV negative males (13.5%, 157/1 161; 5.8%, 67/1 161). The multivariate multinomial logistic regression analysis results showed that larger waist circumference, current smoking and regular physical exercise were associated with heavy alcohol use behavior in HIV positive males, and age ≥30 years, current smoking, regular physical exercise, higher score of depressive symptoms, heterosexual transmission route and baseline CD(4)(+)T cells counts of 200-499 cells/μl were significantly associated with mild/moderate alcohol use behavior in HIV positive males. Conclusions: The alcohol use rate was significantly lower in HIV positive males than in HIV negative males in Taizhou. It is important to strengthen intervention on alcohol drinking behavior and chronic disease risk factors, such as larger waist circumference, smoking and so on.
Collapse
Affiliation(s)
- X T Qiao
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai 200032, China
| | - X X Chen
- Taizhou Prefectural Center for Disease Control and Prevention, Taizhou 318000, China
| | - H J Lin
- Taizhou Prefectural Center for Disease Control and Prevention, Taizhou 318000, China
| | - C X Ning
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai 200032, China
| | - Y Y Xu
- Taizhou Prefectural Center for Disease Control and Prevention, Taizhou 318000, China
| | - W W Shen
- Taizhou Prefectural Center for Disease Control and Prevention, Taizhou 318000, China
| | - D Zhao
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai 200032, China
| | - Y Y Ding
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai 200032, China
| | - N He
- Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai 200032, China
| |
Collapse
|
44
|
Mao XB, Cheng YH, Xu YY. miR-204-5p promotes diabetic retinopathy development via downregulation of microtubule-associated protein 1 light chain 3. Exp Ther Med 2019; 17:2945-2952. [PMID: 30936964 PMCID: PMC6434256 DOI: 10.3892/etm.2019.7327] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2017] [Accepted: 12/12/2018] [Indexed: 12/14/2022] Open
Abstract
Diabetic retinopathy (DR) is a chronic and progressive complication of diabetes mellitus. DR impairs sight due to neuronal and vascular dysfunction in the retina. It is critical to investigate the pathogenesis of DR to develop effective treatment. In the present study, a streptozotocin (STZ)-induced diabetic rat model was constructed and the expression of microRNA (miR)-204-5p and vascular endothelial growth factor (VEGF) were determined. Immunohistochemistry, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting were employed to detect the effects of miR-204-5p on the expression of microtubule-associated protein 1 light chain 3 (LC3B). RT-qPCR analysis demonstrated that miR-204-5p and VEGF were significantly upregulated in the retina tissue of diabetic rats compared with the control group (P<0.01). Immunohistochemistry and western blotting revealed that the protein expression levels of LC3B-II and the ratio of LC3B-II/LC3B-I were significantly suppressed in the diabetes group compared with the control (P<0.01). In retinal tissues, anti-miR-204-5p treatment significantly enhanced the protein expression levels of LC3B-II and the ratio of LC3B-II/LC3B-I and these levels were significantly reduced in response to miR-204-5p mimic treatment compared with the negative miR control (P<0.01). In rat retinal endothelial cells isolated from diabetic rats, anti-miR-204-5p treatment increased the number of autophagic vacuoles, and significantly promoted LC3B-II expression and the LC3B-II/LC3B-I ratio compared with the negative control (P<0.01). The results of the present study revealed that miR-204-5p downregulated the expression of LC3B-II to inhibit autophagy in DR. Therefore, miR-204-5p may be considered as a novel effective therapeutic target during the development of DR.
Collapse
Affiliation(s)
- Xin-Bang Mao
- Department of Ophthalmology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
| | - Yan-Hua Cheng
- Department of Ophthalmology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
| | - Yan-Ying Xu
- Department of Ophthalmology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, P.R. China
| |
Collapse
|
45
|
Hu L, Shu XP, Xu YY, Cheng J, Xu ZQ, Wang JH, Lyu F. [Clinical study on microcirculation changes of bulbar conjunctiva after contact lens wear]. Zhonghua Yan Ke Za Zhi 2019; 55:98-104. [PMID: 30772987 DOI: 10.3760/cma.j.issn.0412-4081.2019.02.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the changes of microcirculation of the bulbar conjunctiva after wearing the contact lens and the relationship between contact lens discomfort and bulbar conjunctiva microcirculation. Methods: Prospective cohort study. The postgraduate students from School of Ophthalmology & Optometry and School of Biomedical Engineering of Wenzhou Medical University were included in this prospective cohort study. The subjects wore soft contact lenses, and the right eye was selected as the experimental eye. The ocular surface disease index (OSDI) questionnaire, Schirmer I and tear break-up time tests were completed before and after wearing the contact lens, and the conjunctival blood flow velocity and microvascular network density were also assessed by using functional slit lamp biomicroscopy. The changes of the indicators after wearing the contact lens were observed and the correlation between the subjective feelings of the wearers and the microcirculation parameters of the bulbar conjunctiva and the main factors affecting the subjective feelings of the wearers were analyzed. Results: Twenty-seven subjects were enrolled in the study, including 8 males and 19 females, aged (22.7±1.6) years. The OSDI score was 11.860± 7.783 before wearing the contact lens and 24.017±12.181 after wearing the contact lens. The comparison before and after wearing the contact lens was statistically significant (t=-4.356, P<0.001). The conjunctival blood flow velocity was (0.534±0.132) mm/s before wearing the contact lens and (0.587±0.134) mm/s after wearing the contact lens. The comparison was statistically significant before and after wearing the lens (t=-2.076, P=0.048). OSDI was positively correlated with blood flow velocity at 1 month after wearing the contact lens (correlation coefficient r=0.383, P=0.048). The test results of the independent variables in the generalized estimating equation model showed that time and blood flow velocity were statistically significant (P<0.05). Conclusions: The blood flow velocity of the bulbar conjunctiva was increased after wearing the contact lens, and the contact lens discomfort of the wearers was positively correlated with the blood flow velocity of the bulbar conjunctiva. (Chin J Ophthalmol, 2019, 55: 98-104).
Collapse
Affiliation(s)
- L Hu
- School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325027, China
| | - X P Shu
- School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325027, China
| | - Y Y Xu
- School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325027, China
| | - J Cheng
- School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325027, China
| | - Z Q Xu
- School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325027, China
| | - J H Wang
- Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States
| | - F Lyu
- School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325027, China
| |
Collapse
|
46
|
Hong Y, Qin YZ, Xu YY, Zhou SH, Wang Y, Xu LP, Zhang XH, Huang XJ, Zhao XS. [Clinical significance of monitoring ETV6-RUNX1 fusion gene expression in children with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi 2019; 38:680-684. [PMID: 28954346 PMCID: PMC7348250 DOI: 10.3760/cma.j.issn.0253-2727.2017.08.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the clinical significance of monitoring ETV6-RUNX1 fusion gene in children with acute lymphoblastic leukemia (ALL) after allogeneic stem cell transplantation (allo-HSCT) . Methods: Clinical data of 13 children received allo-HSCT in Peking University Institute of Hematology from May 2009 to March 2016 were retrospectively collected. The ETV6-RUNX1 gene was examined by real-time quantitative polymerase chain reaction (RQ-PCR) . The correlation between its expression level and the disease status was analyzed. Results: Of 13 enrolled ALL cases, the ETV6-RUNX1 expression of 7 patients converted to positive after transplant at a median time of 137 days (range, 28-270 days) . The expression level of the first positive sample was 0.034% (range, 0.004%-0.061%) . The duration from ETV6-RUNX1 positive to hematological relapse was 196 days (range, 28-666 days) . Four patients experienced relapse at a median time of 294 days (range, 104-803 days) after allo-HSCT. The ETV6-RUNX1 expression converted to positive prior to MRD. Patients with positive ETV6-RUNX1 gene expression pre-transplantation would be more likely to relapse. Conclusion: Monitoring ETV6-RUNX1 by RQ-PCR could be used to evaluate MRD status after allo-HSCT. Patients with positive ETV6-RUNX1 after transplant had a poor prognosis.
Collapse
Affiliation(s)
- Y Hong
- Peking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China
| | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Xu YY, Ouyang J, Zhou M, Xu Y, Li P, Shao XY, Chen B, Zhou RF. [A case report of Kasabach-Merritt syndrome treated with vindesine sulfate]. Zhonghua Nei Ke Za Zhi 2019; 58:143-145. [PMID: 30704202 DOI: 10.3760/cma.j.issn.0578-1426.2019.02.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Affiliation(s)
- Y Y Xu
- Department of Hematology, Nanjing Drum Tower Hospital, Nanjing 210008, China
| | | | | | | | | | | | | | | |
Collapse
|
48
|
Zhang QF, Bao HH, Wu WK, Yan SQ, Sheng J, Xu YY, Gu CL, Huang K, Zhu P, Cao H, Su PY, Tao FB, Hao JH. [Association between early pregnancy bisphenol A exposure and sleep problems among preschool children]. Zhonghua Yu Fang Yi Xue Za Zhi 2018; 52:1018-1022. [PMID: 30392320 DOI: 10.3760/cma.j.issn.0253-9624.2018.10.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyze the association between maternal bisphenol A exposure during early pregnancy and sleep problems among preschool children. Methods: Research subjects were from one of the sub-cohorts(Ma'anshan Cohort) of the China-Anhui Birth Cohort Study (C-ABCS) in Ma'anshan city. The basic situation of pregnant women and sleep information of preschool children were investigated. We selected preschool children whose mother's maternal serum bisphenol A concentrations of the first trimester had been already detected between December 2012 to Januray 2014. 1 259 pairs of mothers and children were included. The concentrations of bisphenol A exposure during early pregnancy were divided into low, medium and high exposure groups according to 25(th) percentile (P(25)) and 75(th) percentile (P(75)) levels. Multivariate multinomial logistic regression model was used to analyze the association between maternal bisphenol A exposure during early pregnancy and sleep-related problems in preschool children. Results: The P(50) (P(25)-P(75)) of serum bisphenol A exposure level during early pregnancy was 0.231 (0.106-0.512) ng/ml. The sleep-related problems scores of 1 259 preschool children were (16.43±3.82) points. The occasional sleep-related problems were detected about 47.8% (602 cases) and frequent sleep-related problems were detected about 18.3% (230 cases). After the adjustment of the confounding factors such as children's gender, age, BMI, sleep position (lying down, sleeping on one's back), the length of time to sleep and the length of sleep at night, in comparison with bisphenol A low exposure group, the OR (95%CI) value of preschool children with occasional sleep-related problems in maternal bisphenol A high exposure group during early pregnancy was 1.44 (1.01-2.06). After the gender stratification, the results showed that in comparison with bisphenol A low exposure group, the OR (95%CI) value of preschool girls with occasional sleep-related problems in maternal bisphenol A medium and high exposure group during early pregnancy were 1.61 (1.05-2.46) and 2.40 (1.42-4.04), respectively. The OR (95%CI) value of preschool girls with frequent sleep-related problems in maternal bisphenol A high exposure group during early pregnancy was 2.64 (1.34-5.17). However, in boys, there was no statistically significant association between maternal bisphenol A exposure during early pregnancy and sleep-related problems (P>0.05). Conclusion: Maternal bisphenol A exposure during early pregnancy might be related to sleep-related problems in preschool children.
Collapse
Affiliation(s)
- Q F Zhang
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University; Anhui Provincial Key Laboratory of Population Health and Aristogenics, Hefei 230032, China
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Xu YY, Liang J, Xia QR. Novel insights into the pharmacological effects of resveratrol on the management of depression: a short review. Pharmazie 2018; 72:499-502. [PMID: 29441975 DOI: 10.1691/ph.2017.7462] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 09/29/2022]
Abstract
Recently, it was suggested that resveratrol (RES), a natural polyphenol, possesses beneficial therapeutic roles in depression. The aim of this review is to discuss the novel potential pharmacological effects of RES on depression. We first consider the pathophysiology of depression and then review the potential antidepressant effects of RES. Apart from the alternation of the monoaminergic system and the molecular markers related to depression, RES might exert an antidepressant-like effect through modulating the HPA axis, BDNF and synaptic vesicle proteins, inflammatory cytokines and oxidative stress, and thyroid hormones. Consumption of RES may represent an alternative strategy to delay the onset and progression of depression, and depressive-like symptoms through multiple pharmacological activities.
Collapse
|
50
|
Lin YJ, Cai QY, Xu YY, Liu HY, Han WH, Wang Y, Tan Y, Xiong HY, Hu AQ, Zheng YJ. [Association and interaction of pre-pregnant body mass index and gestational weight gain of women on neonatal birthweight]. Zhonghua Liu Xing Bing Xue Za Zhi 2018; 39:770-775. [PMID: 29936745 DOI: 10.3760/cma.j.issn.0254-6450.2018.06.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the association between maternal pre-pregnant body mass index and gestational weight gain, as well as their interaction on neonatal birthweight. Methods: We built a cohort in Anqing Municipal Hospital from January 2014 to March 2015, enrolling pregnant women who decided to give birth in this hospital. All women were asked to fill a questionnaire for basic information collection. Medical information of both pregnant women and their newborns were obtained through electronic medical record. Chi-square analysis, multinomial logistic regression, multiplicative and additive interaction methods were used to analyze the association between pre-pregnant body mass index and gestational weight gain as well as their interactions on birth weight of the neonates. Results: A total of 2 881 pregnant women were included in this study. Of the 2 881 newborns, 359 (12.46%) were small for gestational age (SGA) and 273 (9.48%) were large for gestational age (LGA). After adjusting the possible confounding factors, results from the multinomial logistic regression showed that pre-pregnancy underweight women were more possible to deliver SGA (aRR=1.33, 95%CI: 1.02-1.73). If the gestational weight gain was below the recommended criteria, the risk of SGA (aRR=1.64, 95%CI: 1.23-2.19) might increase. Pre-pregnancy overweight/obese could increase the risk of being LGA (aRR=1.86, 95%CI: 1.33-2.60). Maternal gestational weight gain above the recommendation level was associated with higher rates of LGA (aRR=2.03, 95%CI: 1.49-2.78). Results from the interaction analysis showed that there appeared no significant interaction between pre-pregnancy BMI and gestational weight on birthweight. Conclusion: Pre-pregnancy body mass index and gestational weight gain were independently associated with neonatal birthweight while pre-pregnancy BMI and gestational weight gain did not present interaction on birthweight.
Collapse
Affiliation(s)
- Y J Lin
- Department of Public Health Microbiology, School of Public Health, Fudan University, Shanghai 200032, China;Department of Epidemiology, School of Public Health, Fudan University, Shanghai 200032, China
| | - Q Y Cai
- Department of Public Health Microbiology, School of Public Health, Fudan University, Shanghai 200032, China
| | - Y Y Xu
- Department of Laboratory, Anqing Municipal Hospital, Anqing 246003, China
| | - H Y Liu
- Department of Laboratory, Anqing Municipal Hospital, Anqing 246003, China
| | - W H Han
- Department of Obstetrics and Gynecology, Anqing Municipal Hospital, Anqing 246003, China
| | - Y Wang
- Department of Obstetrics and Gynecology, Anqing Municipal Hospital, Anqing 246003, China
| | - Y Tan
- Department of Laboratory, Anqing Municipal Hospital, Anqing 246003, China
| | - H Y Xiong
- Department of Public Health Microbiology, School of Public Health, Fudan University, Shanghai 200032, China
| | - A Q Hu
- Department of Laboratory, Anqing Municipal Hospital, Anqing 246003, China
| | - Y J Zheng
- Department of Public Health Microbiology, School of Public Health, Fudan University, Shanghai 200032, China;Key Laboratory for Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai 200032, China;Key Laboratory for Health Technology Assessment, National Commission of Health and Family Planning, School of Public Health, Fudan University, Shanghai 200032, China
| |
Collapse
|